

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding inhibitor of... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1889/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1889" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding inhibitor of apoptosis proteins" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding inhibitor of apoptosis proteins.">
            <meta name="og:description" content="Read the latest article version by Najoua Lalaoui, David Lawrence Vaux, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="17966">
            <meta name="article-id" content="16439">
            <meta name="dc.title" content="Recent advances in understanding inhibitor of apoptosis proteins">
            <meta name="dc.description" content="The inhibitor of apoptosis proteins (IAPs) are a family of proteins that were chiefly known for their ability to inhibit apoptosis by blocking caspase activation or activity. Recent research has shown that cellular IAP1 (cIAP1), cIAP2, and X-linked IAP (XIAP) also regulate signaling by receptors of the innate immune system&amp;nbsp;by&amp;nbsp;ubiquitylating their substrates. These IAPs thereby act at the intersection of pathways leading to cell death and inflammation. Mutation of IAP genes can impair tissue homeostasis and is linked to several human diseases. Small-molecule IAP antagonists have been developed to treat certain malignant, infectious, and inflammatory diseases. Here, we will discuss recent advances in our understanding of the functions of cIAP1, cIAP2, and XIAP; the consequences of their mutation or dysregulation; and the therapeutic potential of IAP antagonist drugs.">
            <meta name="dc.subject" content="IAP, cell death, innate receptors signalling, inflammation, smac-mimetic">
            <meta name="dc.creator" content="Lalaoui, Najoua">
            <meta name="dc.creator" content="Vaux, David Lawrence">
            <meta name="dc.date" content="2018/12/03">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.16439.1">
            <meta name="dc.source" content="F1000Research 2018 7:1889">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="IAP">
            <meta name="prism.keyword" content="cell death">
            <meta name="prism.keyword" content="innate receptors signalling">
            <meta name="prism.keyword" content="inflammation">
            <meta name="prism.keyword" content="smac-mimetic">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/12/03">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1889">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.16439.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1889">
            <meta name="citation_title" content="Recent advances in understanding inhibitor of apoptosis proteins">
            <meta name="citation_abstract" content="The inhibitor of apoptosis proteins (IAPs) are a family of proteins that were chiefly known for their ability to inhibit apoptosis by blocking caspase activation or activity. Recent research has shown that cellular IAP1 (cIAP1), cIAP2, and X-linked IAP (XIAP) also regulate signaling by receptors of the innate immune system&amp;nbsp;by&amp;nbsp;ubiquitylating their substrates. These IAPs thereby act at the intersection of pathways leading to cell death and inflammation. Mutation of IAP genes can impair tissue homeostasis and is linked to several human diseases. Small-molecule IAP antagonists have been developed to treat certain malignant, infectious, and inflammatory diseases. Here, we will discuss recent advances in our understanding of the functions of cIAP1, cIAP2, and XIAP; the consequences of their mutation or dysregulation; and the therapeutic potential of IAP antagonist drugs.">
            <meta name="citation_description" content="The inhibitor of apoptosis proteins (IAPs) are a family of proteins that were chiefly known for their ability to inhibit apoptosis by blocking caspase activation or activity. Recent research has shown that cellular IAP1 (cIAP1), cIAP2, and X-linked IAP (XIAP) also regulate signaling by receptors of the innate immune system&amp;nbsp;by&amp;nbsp;ubiquitylating their substrates. These IAPs thereby act at the intersection of pathways leading to cell death and inflammation. Mutation of IAP genes can impair tissue homeostasis and is linked to several human diseases. Small-molecule IAP antagonists have been developed to treat certain malignant, infectious, and inflammatory diseases. Here, we will discuss recent advances in our understanding of the functions of cIAP1, cIAP2, and XIAP; the consequences of their mutation or dysregulation; and the therapeutic potential of IAP antagonist drugs.">
            <meta name="citation_keywords" content="IAP, cell death, innate receptors signalling, inflammation, smac-mimetic">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Najoua Lalaoui">
            <meta name="citation_author_institution" content="Cell Signalling and Cell Death, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, 3052, Australia">
            <meta name="citation_author_institution" content="Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, 3050, Australia">
            <meta name="citation_author" content="David Lawrence Vaux">
            <meta name="citation_author_institution" content="Cell Signalling and Cell Death, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, 3052, Australia">
            <meta name="citation_author_institution" content="Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, 3050, Australia">
            <meta name="citation_publication_date" content="2018/12/03">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1889">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.16439.1">
            <meta name="citation_firstpage" content="1889">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1889/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1889.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=17966 /> <input type=hidden id=articleId name=articleId value=16439 /> <input type=hidden id=xmlUrl value="/articles/7-1889/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1889-v1.xml"> <input type=hidden id=article_uuid value=fbb18850-c659-477f-ac38-0eef0d73193c /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding inhibitor of apoptosis proteins"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.16439.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.16439.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1889"
  },
  "headline": "Recent advances in understanding inhibitor of apoptosis proteins",
  "datePublished": "2018-12-03T17:43:45",
  "dateModified": "2018-12-03T17:43:45",
  "author": [
    {
      "@type": "Person",
      "name": "Najoua Lalaoui"
    },    {
      "@type": "Person",
      "name": "David Lawrence Vaux"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "The inhibitor of apoptosis proteins (IAPs) are a family of proteins that were chiefly known for their ability to inhibit apoptosis by blocking caspase activation or activity. Recent research has shown that cellular IAP1 (cIAP1), cIAP2, and X-linked IAP (XIAP) also regulate signaling by receptors of the innate immune system by ubiquitylating their substrates. These IAPs thereby act at the intersection of pathways leading to cell death and inflammation. Mutation of IAP genes can impair tissue homeostasis and is linked to several human diseases. Small-molecule IAP antagonists have been developed to treat certain malignant, infectious, and inflammatory diseases. Here, we will discuss recent advances in our understanding of the functions of cIAP1, cIAP2, and XIAP; the consequences of their mutation or dysregulation; and the therapeutic potential of IAP antagonist drugs."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1889.html",
            "name": "Recent advances in understanding inhibitor of apoptosis proteins"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding inhibitor of apoptosis proteins </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=17966 data-id=16439 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16439.1" data-recommended="" data-doi="10.12688/f1000research.16439.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1889/v1/pdf?article_uuid=fbb18850-c659-477f-ac38-0eef0d73193c" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-16439-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-16439-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-16439-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Lalaoui N and Vaux DL. Recent advances in understanding inhibitor of apoptosis proteins [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1889 (<a class=new-orange href="https://doi.org/10.12688/f1000research.16439.1" target=_blank>https://doi.org/10.12688/f1000research.16439.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-16439-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=16439 id=track-article-signin-16439 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16439?target=/articles/7-1889.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17966 /> <input name=articleId type=hidden value=16439 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding inhibitor of apoptosis proteins</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:lalaoui@wehi.edu.au" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Najoua Lalaoui</span></a><a href="https://orcid.org/0000-0002-0165-3324" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-0165-3324</div><sup>1,2</sup>,&nbsp;</span><span class=""><a href="mailto:vaux@wehi.edu.au" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>David Lawrence Vaux</span></a><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:lalaoui@wehi.edu.au" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Najoua Lalaoui</span></a><a href="http://orcid.org/0000-0002-0165-3324" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-0165-3324</div><sup>1,2</sup>,&nbsp;</span><span class=""><a href="mailto:vaux@wehi.edu.au" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>David Lawrence Vaux</span></a><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 03 Dec 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.16439.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Cell Signalling and Cell Death, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, 3052, Australia<br/> <sup>2</sup> Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, 3050, Australia<br/> <p> <div class=margin-bottom> Najoua Lalaoui <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> David Lawrence Vaux <br/> <span>Roles: </span> Funding Acquisition, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=42210-41425></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=42211-41426></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> The inhibitor of apoptosis proteins (IAPs) are a family of proteins that were chiefly known for their ability to inhibit apoptosis by blocking caspase activation or activity. Recent research has shown that cellular IAP1 (cIAP1), cIAP2, and X-linked IAP (XIAP) also regulate signaling by receptors of the innate immune system&nbsp;by&nbsp;ubiquitylating their substrates. These IAPs thereby act at the intersection of pathways leading to cell death and inflammation. Mutation of IAP genes can impair tissue homeostasis and is linked to several human diseases. Small-molecule IAP antagonists have been developed to treat certain malignant, infectious, and inflammatory diseases. Here, we will discuss recent advances in our understanding of the functions of cIAP1, cIAP2, and XIAP; the consequences of their mutation or dysregulation; and the therapeutic potential of IAP antagonist drugs. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> IAP, cell death, innate receptors signalling, inflammation, smac-mimetic </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Najoua Lalaoui (<a href="mailto:lalaoui@wehi.edu.au">lalaoui@wehi.edu.au</a>) <br> David Lawrence Vaux (<a href="mailto:vaux@wehi.edu.au">vaux@wehi.edu.au</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding authors:</b> Najoua Lalaoui, David Lawrence Vaux </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> DLV was on the scientific advisory board of TetraLogic, and he and NL have patent applications related to birinapant. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported by project grant #1145588 from the Cancer Australia and Cure Cancer Australia Foundation (to NL), Victorian Cancer Agency Mid-career Fellowship #17030 (to NL), Australian National Health and Medical Research Council (NHMRC) Program Grant #1113133 (to DLV), NHMRC Fellowship #1020136 (to DLV), and Leukemia and Lymphoma Society SCOR grant #7001-13 (to DLV). This work was made possible by operational infrastructure grants through the Australian government’s Independent Research Institute Infrastructure Support Scheme and the Victorian state government’s Operational Infrastructure Support. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Lalaoui N and Vaux DL. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Lalaoui N and Vaux DL. Recent advances in understanding inhibitor of apoptosis proteins [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1889 (<a href="https://doi.org/10.12688/f1000research.16439.1" target=_blank>https://doi.org/10.12688/f1000research.16439.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 03 Dec 2018, <b>7</b>(F1000 Faculty Rev):1889 (<a href="https://doi.org/10.12688/f1000research.16439.1" target=_blank>https://doi.org/10.12688/f1000research.16439.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 03 Dec 2018, <b>7</b>(F1000 Faculty Rev):1889 (<a href="https://doi.org/10.12688/f1000research.16439.1" target=_blank>https://doi.org/10.12688/f1000research.16439.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d29458e177>Introduction</h2><p class="" id=d29458e180>The inhibitor of apoptosis proteins (IAPs) are a family of proteins that were first identified in insect baculoviruses<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup>. These viral IAPs were found to block defensive apoptosis in order to facilitate viral replication<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup>. Subsequently, cellular homologs have been identified in both invertebrates and vertebrates. Like viral IAPs, some cellular IAPs can inhibit apoptosis. Cellular and viral IAPs are characterized by the presence of baculoviral repeat domain (BIR) repeats. This review will focus on the most intensively studied mammalian IAPs, which are cellular IAP1 (cIAP1), cIAP2, and X-linked IAP (XIAP).</p><p class="" id=d29458e197>Mammalian IAPs were initially thought to inhibit cell death only by directly binding to caspases. However, only XIAP is able to bind caspase-3 and -9<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. Upon apoptotic stimuli, IAP inhibitors, including Smac/Diablo and HtrA2/Omi, are released from the mitochondria and bind to XIAP’s BIR domains, releasing active caspases into the cytosol<sup><a href="#ref-5">5</a></sup>. Unlike XIAP, cIAP1 and 2 are poor direct caspase inhibitors<sup><a href="#ref-6">6</a></sup>. Instead, they bind to tumor necrosis factor (TNF) receptor-associated factors (TRAFs) via their BIR1 domains<sup><a href="#ref-7">7</a></sup> to block cell death induced by TNF receptor 1 (TNFR1) by promoting the activation of signaling pathways that induce the expression of pro-survival proteins.</p><p class="" id=d29458e219>Recent advances in understanding of IAP function from genetics, biochemistry, structural biology, and medicinal chemistry have shown that IAPs have roles beyond inhibiting cell death. All three IAPs have a carboxy-terminal RING (really interesting new gene) domain that allows them to act as ubiquitin E3 ligases that can ubiquitylate associated proteins as well as themselves. IAPs can regulate innate immune responses by limiting non-canonical nuclear factor kappa B (NFκB) signaling, promoting canonical NFκB and mitogen-activated protein kinase (MAPK) signaling, and inhibiting both caspase-dependent and -independent cell death. Drugs that antagonize IAPs, termed “Smac-mimetics”, have been developed to promote the death of cancer cells and those bearing intracellular infections. Use of these drugs in pre-clinical models has revealed additional roles of IAPs that might be exploited to treat certain inflammatory conditions and to enhance anti-tumor immunity.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29458e225>IAP and TNF signaling</h2><div class=section><a name=d29458e228 class=n-a></a><h3 class=section-title>TNF-induced survival</h3><p class="" id=d29458e233>Despite its name, TNF does not induce cell death in the majority of cell types. However, cell death can occur when canonical NFκB activation is delayed or blocked. Binding of TNF to TNFR1 induces the recruitment of TRADD, RIPK1, TRAF2, and cIAP1 and 2 to form complex I at the plasma membrane. cIAP1 binds to TRAF2 through both its BIR1 and its UBA domains<sup><a href="#ref-8">8</a>–<a href="#ref-11">11</a></sup>. Within complex I, cIAP1 and 2 conjugate K11-, K48-, and K63-linked ubiquitin chains to themselves and other complex I components such as RIPK1<sup><a href="#ref-12">12</a>–<a href="#ref-16">16</a></sup>. cIAP-mediated ubiquitylation of components of complex I leads to the recruitment of the linear ubiquitin chain assembly complex (LUBAC), which in turn linearly ubiquitylates several components of the complex I, including TNFR1, TRADD, RIPK1, or NEMO<sup><a href="#ref-17">17</a>–<a href="#ref-22">22</a></sup>. Both K63-linked and linear ubiquitin chains serve as docking sites for TAB2/3/TAK1 and the IKK subunit NEMO<sup><a href="#ref-23">23</a>–<a href="#ref-27">27</a></sup>. Subsequently, TAK1 phosphorylates IKK2 and MAPK kinases<sup><a href="#ref-28">28</a></sup>, leading to the transcription of NFκB-dependent and MAPK-dependent genes that induce inflammation, proliferation, and cell survival (<a href="#f1">Figure 1</a>).</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/17966/883411c9-46f8-4a0f-a225-30c8795703d5_figure1.gif"><img alt="883411c9-46f8-4a0f-a225-30c8795703d5_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/17966/883411c9-46f8-4a0f-a225-30c8795703d5_figure1.gif"></a><div class=caption><h3>Figure 1. Regulation of innate receptor signaling pathways by inhibitor of apoptosis proteins (IAPs).</h3><p id=d29458e282>Tumor necrosis factor (TNF) binding to TNF receptor 1 (TNFR1) triggers complex I formation, in which cIAP1 and 2 ubiquitylate RIPK1. This leads to the induction of canonical (canon.) nuclear factor kappa B (NFκB)- and mitogen-activated protein kinase (MAPK)-dependent genes, including <i>cFlar</i> encoding cFLIP. Subsequently, cytosolic complex II containing FADD, caspase-8, RIPK1, RIPK3, and cFLIP is formed. In this complex, cFLIP inhibits caspase-8 activation to block apoptosis and necroptosis. Inhibition of cIAP1 and 2 by Smac-mimetic drugs impairs canonical NFκB activation and accelerates the formation of complex II, which leads to apoptosis. When caspase-8 activation is blocked within complex II, RIPK1 and 3 are not cleaved and necroptosis is activated. Stimulation of nucleotide-binding oligomerization domain 1/2 (NOD1/2) receptors induces RIPK2 ubiquitylation by XIAP and activates the transcription of NFκB- and MAPK-dependent cytokines such as TNF, which amplifies the inflammatory signal. Binding of pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) to Toll-like receptors (TLRs) leads to the recruitment of the Myd88/TRAF3/6/cIAP1/2 complex. Within this complex, cIAP1 and 2 ubiquitylate TRAF3, inducing its degradation and increasing the expression of cytokines and chemokines. The other TLR adaptor, TRIF, recruits RIPK1 via its RIP homotypic interaction motif (RHIM) domain (yellow). Upon TLR activation, inhibition of IAPs by Smac-mimetics promotes the formation of the ripoptosome, which has a composition similar to that of complex II. TLR-induced expression of TNF and TNFR2 triggers cIAP1/2 degradation and a subsequent accumulation of NFκB-inducing kinase (NIK), which activates non-canonical (non canon.) NFκB-dependent genes. In the context of XIAP deficiency, the degradation of cIAP1 and 2 by TNFR2 leads to the formation of complex II. Activation of complex II or the ripoptosome can activate pyroptosis after TLR priming. TRAF, tumor necrosis factor receptor-associated factor.</p></div></div><p class="" id=d29458e292>According to this model, ubiquitylation of RIPK1 mediated by cIAP1 and 2 and LUBAC serves as a scaffold to activate NFκB and MAPK, providing inflammatory and survival outcomes (<a href="#f1">Figure 1</a>). However, several reports have questioned parts of this model. For instance, in Jurkat T cells lacking RIPK1, there was no activation of NFκB in response to TNF, suggesting a requirement for RIPK1 so that TNF could activate NFκB. In contrast, in primary fibroblasts and T cells, TNF was able to activate NFκB in the absence of TRADD or RIPK1<sup><a href="#ref-24">24</a>,<a href="#ref-29">29</a>–<a href="#ref-32">32</a></sup>. Similarly, the deletion of cIAP1/2 genes markedly delayed, but did not prevent, TNF-induced activation of NFκB in mouse embryonic fibroblasts (MEFs)<sup><a href="#ref-11">11</a>,<a href="#ref-33">33</a></sup>. Observations such as these have led to a proposal that TNF induces two waves of IKK activation occurring a few minutes apart<sup><a href="#ref-34">34</a></sup>. The first is dependent on RIPK1 ubiquitylation and the second on LUBAC recruitment, which allows further recruitment of IKKs<sup><a href="#ref-34">34</a></sup>. It is therefore plausible that the first early wave has at times been missed and this could explain why in some cell types RIPK1 has been found to be dispensable for canonical NFκB activation<sup><a href="#ref-34">34</a></sup>. It also might account for why the loss of LUBAC components reduces or delays the activation of NFκB by TNF<sup><a href="#ref-18">18</a>–<a href="#ref-21">21</a>,<a href="#ref-35">35</a>–<a href="#ref-39">39</a></sup>. However, because both waves depend on TRAF2 and cIAP1, this does not explain how canonical NFκB is activated in the absence of cIAP1 and 2. Perhaps, in some cell types, in the absence of cIAP1 and 2, there are backup signaling mechanisms to ensure the transcription of survival and inflammatory genes. In other cell types, the absence of backup signaling would terminate the inflammatory response.</p></div><div class=section><a name=d29458e342 class=n-a></a><h3 class=section-title>TNF-induced cell death</h3><p class="" id=d29458e347>While there remains uncertainty about whether cIAP1 and 2 are absolutely necessary for activation of the canonical NFκB pathway, there is general agreement that IAPs prevent TNF-induced cell death. Internalization of complex I leads to the recruitment of FADD, caspase-8, and RIPK3, forming a cytosolic cell death-promoting platform referred to as complex II<sup><a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>. Signaling from complex I stimulates transcription of the <i>CFLAR</i> gene encoding cFLIP, a structural homolog of caspase-8 that lacks caspase activity. Binding of cFLIP to caspase-8 limits caspase-8 activity so that a restricted number of substrates, such as RIPK1, are cleaved whereas others, such as pro-caspase-3 or Bid, are not<sup><a href="#ref-42">42</a>–<a href="#ref-45">45</a></sup> (<a href="#f1">Figure 1</a>).</p><p class="" id=d29458e370>Cleavage of RIPK1 is believed to allow the dissociation of complex II and also prevents RIPK1 from oligomerizing with RIPK3 (another substrate of the cFLIP/caspase-8 heterodimer). Accordingly, if caspase-8 activity is compromised, uncleaved RIPK1 and 3 oligomerize to form a complex called the necrosome, in which RIPK3 is auto-phosphorylated and in turn phosphorylates MLKL, which causes a form of cell death known as necroptosis<sup><a href="#ref-41">41</a>,<a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup>. Consistent with the role for cIAP1 and 2 as ubiquitin ligases for RIPK1, the absence of, a decrease in, or mutation of the BIR or UBA domains of cIAP1 and 2 allows RIPK1 to remain or become deubiquitylated, so that complex I more rapidly transitions into complex II, promoting cell death<sup><a href="#ref-11">11</a>,<a href="#ref-15">15</a>,<a href="#ref-48">48</a></sup>. This would have an immediate effect in addition to the slower effect of reduced activation of NFκB leading to less production of cFLIP (<a href="#f1">Figure 1</a>).</p><p class="" id=d29458e396>In some circumstances, the absence of just XIAP can also allow TNF to induce cell death, but less is known about how this occurs, compared with induction of cell death in the absence of cIAP1 and 2<sup><a href="#ref-49">49</a>,<a href="#ref-50">50</a></sup>. It has been speculated that XIAP blocks RIPK1 ubiquitylation within complex II in a RIPK3-dependent manner<sup><a href="#ref-50">50</a></sup>. Consistent with this, ubiquitylated RIPK1 species are present in complex II or the necrosome when all IAPs are inhibited<sup><a href="#ref-51">51</a></sup>. Perhaps cIAP1 and 2 ubiquitylate RIPK1 in complex I, thus limiting RIPK1’s entry into complex II, whereas XIAP limits RIPK1’s ubiquitylation within complex II to block its activation.</p><p class="" id=d29458e414>It is important to note that, in some cells, inhibition of cIAP1 and 2 can allow spontaneous formation of a RIPK1/FADD/caspase-8/FLIP complex called the “ripoptosome” independently of the addition of TNF or other death ligands such as TRAIL and FasL<sup><a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup>. Formation and activation of this complex are further enhanced in the absence of XIAP<sup><a href="#ref-52">52</a>–<a href="#ref-54">54</a></sup> (<a href="#f1">Figure 1</a>). Whereas the role of cIAP1 and 2 in limiting ripoptosome formation is likely to be due to decreased RIPK1 ubiquitylation, the exact role of XIAP in inhibiting ripoptosome formation is not known.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29458e438>IAPs and microbial sensors</h2><div class=section><a name=d29458e441 class=n-a></a><h3 class=section-title>Toll-like receptors and inflammasomes</h3><p class="" id=d29458e446>Toll-like receptors (TLRs) recognize pathogen-associated and damage-associated molecular patterns known as PAMPs and DAMPs, respectively. TLRs transduce signals through the adaptor proteins MyD88 and TRIF<sup><a href="#ref-55">55</a></sup>. When PAMPs and DAMPs bind TLRs, those dependent on MyD88 recruit TRAF6, and the TRIF-dependent TLRs recruit both TRAF6 and TRAF3. TRAF6 activates NFκB and MAPK, whereas TRAF3 is believed to decrease activity of the MAPK signaling pathway and mediate IRF3-dependent production of type 1 interferon (IFN)<sup><a href="#ref-55">55</a></sup>. It has been proposed that, in the MyD88 complex, TRAF6 K63 ubiquitylates cIAP1 and 2<sup><a href="#ref-56">56</a>,<a href="#ref-57">57</a></sup>. By K48 ubiquitylating TRAF3, cIAP1/2 cause its degradation and limit MAPK-dependent production of cytokines and chemokines without affecting the production of type I IFN<sup><a href="#ref-56">56</a></sup> (<a href="#f1">Figure 1</a>). Another study suggested that cIAP1 and 2 function in concert with TRAF2/3 to mediate the degradation of c-Rel and IRF5, limiting the production of pro-inflammatory cytokines<sup><a href="#ref-58">58</a></sup>.</p><p class="" id=d29458e476>Although there are only a few reports on the role of IAPs in regulating TLR-induced production of cytokines, there is a substantial body of work showing that IAPs block cell death induced by TLRs. IAPs prevent TLR-dependent ripoptosome formation and a TLR-dependent, inflammasome-induced form of cell death termed “pyroptosis”. TRIF is the adaptor that links TLRs to the ripoptosome, mediated by its RIP homotypic interaction motif (RHIM) domain that binds to the RHIM domains of RIPK1/3<sup><a href="#ref-59">59</a></sup>. Upon TLR stimulation, formation and activation of the ripoptosome are limited by IAPs<sup><a href="#ref-52">52</a>,<a href="#ref-60">60</a></sup>. Accordingly, inhibition of IAPs by Smac-mimetics sensitizes cells to TLR-induced apoptosis and necroptosis<sup><a href="#ref-54">54</a>,<a href="#ref-59">59</a>–<a href="#ref-63">63</a></sup> (<a href="#f1">Figure 1</a>).</p><p class="" id=d29458e503>IAPs also play key roles in limiting pyroptosis, but there are conflicting views on how they do so. The nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family constitutes some of the sensors that trigger the formation of inflammasomes when they are bound by PAMPs or DAMPs in the cytoplasm. Their oligomerization results in (a) caspase-1 activation leading to pyroptosis to clear stressed cells and pathogens and (b) cleavage of interleukin-1 beta (IL-1β) to alert the immune system. Whereas Labbé <i>et al</i>.<sup><a href="#ref-64">64</a></sup> found that cIAP1 and 2 are obligatory for IL-1β processing, other groups failed to find a role for cIAP1 and 2 in IL-1β maturation but instead showed that XIAP together with cIAP1 and 2 acted in the opposite way by preventing the cleavage of IL-1β<sup><a href="#ref-50">50</a>,<a href="#ref-54">54</a>,<a href="#ref-63">63</a>–<a href="#ref-66">66</a></sup>. Labbé <i>et al</i>. showed that in macrophages cIAP1 and 2 K63 ubiquitylate caspase-1 to enhance NLRP3 and NLRC4 inflammasome activity<sup><a href="#ref-64">64</a></sup>. In contrast, other groups found that all three IAPs limit caspase-8-dependent activation of IL-1β processing<sup><a href="#ref-50">50</a>,<a href="#ref-54">54</a>,<a href="#ref-63">63</a>,<a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup>.</p><p class="" id=d29458e550>In macrophages, dendritic cells, and neutrophils bearing XIAP-null or -RING mutations, TLR ligation was sufficient to drive IL-1β maturation and NLRP3 activation<sup><a href="#ref-50">50</a>,<a href="#ref-54">54</a>,<a href="#ref-63">63</a>,<a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup>. TLR stimulation promoted the expression of both TNF and TNFR2<sup><a href="#ref-63">63</a></sup>. Binding of TNF to TNFR2 caused cIAP degradation<sup><a href="#ref-63">63</a>,<a href="#ref-67">67</a></sup>. Thus, in the absence of XIAP, TNFR2-induced cIAP degradation allows the formation of TNFR1-dependent complex II as well as the TRIF-dependent ripoptosome<sup><a href="#ref-50">50</a>,<a href="#ref-54">54</a>,<a href="#ref-63">63</a>,<a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup>. In these complexes, activated caspase-8 leads to IL-1β processing by both NLRP3-dependent and -independent mechanisms<sup><a href="#ref-50">50</a>,<a href="#ref-54">54</a>,<a href="#ref-63">63</a>,<a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup> (<a href="#f1">Figure 1</a>). Accordingly, combined depletion of XIAP and cIAP1 and 2 profoundly enhanced IL-1β cleavage<sup><a href="#ref-50">50</a>,<a href="#ref-54">54</a>,<a href="#ref-63">63</a>,<a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup>. Importantly, RIPK3 was also required for IL-1β processing when IAPs were inhibited<sup><a href="#ref-50">50</a>,<a href="#ref-54">54</a>,<a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup>. Upon IAP inhibition, RIPK3 seems to enhance caspase-8 activity and the consequent processing of IL-1β<sup><a href="#ref-63">63</a>,<a href="#ref-65">65</a></sup>.</p><p class="" id=d29458e653>The differences in these observations could be due to the different genetic backgrounds of the knockout mice. Labbé <i>et al</i>. used cIAP1/2 knockout mice generated in a 129/sv background. 129/sv strains also carry a passenger mutation that inactivates caspase-11. cIAP1 and caspase-11 genes are too close in the genome to be segregated by recombination, even after extensive backcrossing<sup><a href="#ref-68">68</a></sup>. Therefore, all cIAP1 (and potentially cIAP2) knockout mice generated in a 129/sv background are likely to be mutant for caspase-11<sup><a href="#ref-68">68</a></sup>. Because caspase-11 can cleave IL-1β in the NLRP3 non-canonical inflammasome, the effect seen in 129/Sv cIAP1 (and potentially cIAP2) knockouts might be due to non-functional caspase-11<sup><a href="#ref-69">69</a></sup>.</p><p class="" id=d29458e671>Although the main activator of IL-1β is caspase-1, a role for caspase-8 in IL-1β maturation has been supported by several studies. Caspase-8 can mediate cleavage and secretion of IL-1β downstream of TLR and Fas signaling pathways, in the context of bacterial or fungal infections, during endoplasmic reticulum stress, or upon chemotherapeutic drugs<sup><a href="#ref-70">70</a>–<a href="#ref-77">77</a></sup>. None of these reports showed that IAPs had to be absent for caspase-8 to process IL-1β. However, it is worth keeping in mind that TLR signaling drives the expression of TNFR2, which in turn induces the degradation of cIAP1 and 2<sup><a href="#ref-63">63</a></sup>. Therefore, it is plausible that bacteria or fungi that trigger TLRs reduce cIAP1/2 levels, leading to activation of complex II and the ripoptosome. In addition, some pathogens, such as <i>Shigella</i>, can both directly and indirectly inhibit cIAP1/2 functions, leading to activation of the inflammasome<sup><a href="#ref-78">78</a>,<a href="#ref-79">79</a></sup>. Similarly, it has been shown that chemotherapeutic drugs, such as etoposide, decrease IAP levels and trigger ripoptosome formation<sup><a href="#ref-53">53</a></sup>. A role for RIPK3 in promoting IL-1β processing has also been reported by others<sup><a href="#ref-73">73</a>,<a href="#ref-80">80</a></sup>. The exact molecular mechanism by which RIPK3 regulates IL-1β processing is still under investigation, but there is evidence that, in the absence of IAPs, RIPK3 favors ubiquitylation of RIPK1 and caspase-8, which presumably facilitates their activation within complex II or the ripoptosome<sup><a href="#ref-50">50</a>,<a href="#ref-51">51</a>,<a href="#ref-63">63</a>,<a href="#ref-65">65</a>,<a href="#ref-81">81</a></sup>. All together, these studies indicate that IAPs not only restrict RIPK1’s cytotoxic function but also prevent RIPK3 from enhancing IL-1β secretion.</p></div><div class=section><a name=d29458e724 class=n-a></a><h3 class=section-title>NOD signaling</h3><p class="" id=d29458e729>NOD1 and NOD2 are intracellular members of the NLR family that recognize bacterial peptidoglycan derivatives. Their ligation leads to NFκB- and MAPK-dependent production of inflammatory mediators. IAPs regulate the NOD1/2 signaling pathway, and XIAP is the key player. Just as TNFR1 triggers cIAP1/2-mediated ubiquitylation of RIPK1 in complex I, NOD2 stimulation induces XIAP-mediated RIPK2 polyubiquitylation, which serves as a platform to recruit TAK1 and the IKKs<sup><a href="#ref-82">82</a>–<a href="#ref-84">84</a></sup>. XIAP interacts via its BIR2 with the kinase domain of RIPK2 to ubiquitylate RIPK2, presumably on lysines 209, 410, and 538<sup><a href="#ref-84">84</a>–<a href="#ref-88">88</a></sup>. RIPK2 ubiquitylation by XIAP recruits LUBAC, which in turn linearly ubiquitylates RIPK2, increasing the recruitment of IKK subunits<sup><a href="#ref-89">89</a></sup> (<a href="#f1">Figure 1</a>). Accordingly, deficiency of XIAP in mice completely abrogates NOD1/2 signaling and reduces responses to <i>Listeria</i> and <i>Chlamydophila pneumoniae</i> infections<sup><a href="#ref-49">49</a>,<a href="#ref-89">89</a>,<a href="#ref-90">90</a></sup>. Importantly, several studies have demonstrated that the ortholog of XIAP in <i>Drosophila</i>, DIAP2, is essential to resist Gram-negative bacterial infection<sup><a href="#ref-91">91</a>–<a href="#ref-95">95</a></sup>. These studies in flies demonstrated an evolutionarily conserved function of XIAP in regulating innate immunity.</p><p class="" id=d29458e780>It has been reported that, in addition to XIAP, cIAP1 and 2 can mediate the ubiquitylation of RIPK2; however, the exact role of this ubiquitylation in NOD2 signaling is still under debate<sup><a href="#ref-86">86</a>,<a href="#ref-89">89</a>,<a href="#ref-96">96</a>–<a href="#ref-98">98</a></sup>. Although there is general agreement that cIAP1 regulates NOD1/2 signaling, the mechanisms proposed differ. Bertrand <i>et al</i>. proposed that cIAP1/2-mediated ubiquitylation of RIPK2 favors activation of NFκB and MAPK induced by NOD2<sup><a href="#ref-96">96</a></sup>. In contrast, although several studies showed that loss of cIAP1 and 2 affects RIPK2 ubiquitylation<sup><a href="#ref-86">86</a>,<a href="#ref-89">89</a>,<a href="#ref-96">96</a></sup>, two groups did not find evidence that cIAP1 and 2 directly regulate NOD2-induced NFκB and MAPK activation<sup><a href="#ref-86">86</a>,<a href="#ref-98">98</a></sup>. Instead, it has been proposed that cIAP1 increases NOD2-induced cytokine production through a TNFR1 signaling pathway<sup><a href="#ref-98">98</a></sup> (<a href="#f1">Figure 1</a>). Consistent with this, TNFR1 knockout mice have a blunted response to NOD2 stimulation<sup><a href="#ref-98">98</a></sup>. As with the discordant views of how cIAP1 and 2 regulate the inflammasome, these discrepancies might be due to the use of cIAP knockouts generated in different genetic backgrounds (129/sv versus C57BL/6J) and the use of different methods to stimulate NOD signaling (DOTAP versus IFNγ priming)<sup><a href="#ref-96">96</a>,<a href="#ref-98">98</a></sup>.</p><p class="" id=d29458e839>Conversely, there is no doubt that XIAP plays an essential role in NOD signaling. Its importance is reflected by the existence of <i>XIAP</i> mutations contributing to human diseases in which defects in NOD signaling play a role in the pathogenesis<sup><a href="#ref-86">86</a>,<a href="#ref-99">99</a>–<a href="#ref-101">101</a></sup>. XIAP deficiency in humans causes a rare immunodeficiency syndrome characterized by high susceptibility to viruses such as Epstein–Barr virus (EBV), cytomegalovirus (CMV), or herpesvirus 6<sup><a href="#ref-102">102</a></sup>. This syndrome is frequently referred to as X-linked lymphoproliferative disease 2 (XLP2) because the first reported XLP2 patients showed a susceptibility to EBV infections like that in XPL1 patients<sup><a href="#ref-103">103</a></sup>. However, this classification is currently under debate because so far no reported XIAP-deficient/XLP2 patient has developed lymphomas<sup><a href="#ref-104">104</a>–<a href="#ref-107">107</a></sup>. XIAP-deficient patients are affected with a range of immunological defects that can occur independently of each other. These include hemophagocytic lymphohistiocytosis, recurrent splenomegaly, and inflammatory bowel disease (IBD) resembling Crohn’s disease<sup><a href="#ref-102">102</a></sup>. Given that <i>NOD2</i> mutations are the strongest genetic factor associated with Crohn’s disease<sup><a href="#ref-108">108</a>,<a href="#ref-109">109</a></sup>, the pathological mechanism underlying IBD in XIAP deficiency is likely to be due to impaired NOD signaling. Accordingly, like those from NOD2-associated Crohn’s patients, cells from XIAP-deficient patients have reduced responses to NOD2 activation<sup><a href="#ref-86">86</a>,<a href="#ref-99">99</a>–<a href="#ref-101">101</a></sup>. On the other hand, it has been shown that NOD signaling can sense viral products<sup><a href="#ref-110">110</a>,<a href="#ref-111">111</a></sup>. Thus, the impaired response to NOD signaling in XIAP-deficient patients might contribute to their susceptibility to viral infections.</p><p class="" id=d29458e902>Nevertheless, defects in NOD signaling do not account for all of the signs and symptoms seen in XIAP deficiency. The role for XIAP in regulating apoptosis and the inflammasome also appears in other clinical manifestations. For instance, adaptive and innate-like T lymphocytes from XIAP patients are more sensitive to cell death induced by death receptors <i>in vitro</i><sup><a href="#ref-103">103</a>,<a href="#ref-104">104</a>,<a href="#ref-106">106</a></sup>. This propensity to apoptosis might compromise immune responses during viral infections. In addition, it is important to note that, although there is no direct proof of a role in aberrant inflammasome activation, some XIAP patients had high levels of IL-18 in their bloodstream<sup><a href="#ref-112">112</a></sup>. Like IL-1β, IL-18 is cleaved and released upon inflammasome activation. Given that loss of XIAP in mice can activate the inflammasome, it is plausible that loss of XIAP function in these patients drives the secretion of IL-18 and the consequent associated inflammatory phenotypes.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29458e925>IAPs and tissue homeostasis</h2><div class=section><a name=d29458e928 class=n-a></a><h3 class=section-title>Gene deletion</h3><p class="" id=d29458e933>Different genetic knockouts and mutants of murine genes for XIAP, cIAP1, and cIAP2 have revealed that they work in overlapping and partially redundant ways to ensure proper embryonic development and tissue homeostasis. Mice lacking cIAP1 or 2 or XIAP are viable with no overt phenotype<sup><a href="#ref-48">48</a>,<a href="#ref-113">113</a>,<a href="#ref-114">114</a></sup>. However, unlike the co-deletion of <i>Xiap/Birc4</i> and <i>Ciap2/Birc3</i>, which leads to viable mice, co-deletion of <i>Ciap1/Birc2</i> and <i>Ciap2/Birc3</i>, or co-deletion of <i>Ciap1/Birc2</i> and <i>Xiap/Birc4</i>, results in early embryonic lethality on a pure C57BL/6 background<sup><a href="#ref-48">48</a></sup>. This suggests that cIAP1 alone is enough to achieve all essential IAP functions and also that XIAP can co-operate with cIAP2 to accomplish cIAP1’s functions. The lethality of mice lacking both XIAP and cIAP1 was nevertheless surprising. Because of the close linkage of cIAP1 and 2 genes (~15 kb), it has been assumed that they were the result of gene duplication and therefore might have redundant functions. Consistent with this idea, mice lacking XIAP and cIAP1 in a 129/Sv background are viable<sup><a href="#ref-115">115</a></sup>. These opposite results might be due to the different genetic background of the mice. Thus, it is plausible that passenger mutations such as the mutation on <i>caspase-11</i> account for 129/Sv <i>Xiap<sup>−/−</sup>Ciap1<sup>−/−</sup></i> viability. Conversely, Heard <i>et al</i>. found that the level of cIAP2 in the C57BL/6J <i>Xiap<sup>−/−</sup>Ciap1<sup>−/−</sup></i> MEFs was greatly reduced, which could explain why C57BL/6J <i>Xiap<sup>−/−</sup>Ciap1<sup>−/−</sup></i> mice were not viable<sup><a href="#ref-115">115</a></sup>. The reason for the difference in cIAP2 levels between these two sets of <i>Xiap<sup>−/−</sup>Ciap1<sup>−/−</sup></i> MEFs is still unclear. The use of CRISP/Cas9 technology might help to determine whether cIAP2 can compensate cIAP1 when XIAP is absent<sup><a href="#ref-115">115</a>,<a href="#ref-116">116</a></sup>.</p><p class="" id=d29458e1023>The lethality of <i>Ciap1<sup>−/−</sup>Ciap2<sup>−/−</sup></i> and <i>Xiap<sup>−/−</sup>Ciap1<sup>−/−</sup></i> mice (on a pure C57BL/6J background) occurs at E10.5 and is caused by hemorrhages and cardiovascular failure<sup><a href="#ref-48">48</a></sup>. Similar lethal defects arose in <i>Fadd<sup>−/−</sup></i>, <i>Cflar<sup>−/−</sup></i>, <i>Casp8<sup>−/−</sup></i>, <i>Hoip<sup>−/−</sup></i>, and <i>Hoil<sup>−/−</sup></i> mutant mice<sup><a href="#ref-35">35</a>,<a href="#ref-38">38</a>,<a href="#ref-48">48</a>,<a href="#ref-117">117</a>–<a href="#ref-119">119</a></sup>. Importantly, loss of <i>Casp8</i> or <i>Hoip</i> just in the endothelia phenocopied the E10 lethality, demonstrating that the cardiac defect and hemorrhages were due to an endothelial defect<sup><a href="#ref-35">35</a>,<a href="#ref-120">120</a></sup>. Because IAPs, FADD, FLIP, caspase-8, and HOIP/HOIL all participate in the regulation of cell death induced by TNFR1, a common mechanism dependent on TNFR1 might account for the lethality in all of these knockouts. Accordingly, loss of <i>Tnfr1</i> delayed <i>Fadd<sup>−/−</sup></i>, <i>Casp8<sup>−/−</sup></i>, <i>Hoil<sup>−/−</sup></i>, <i>Hoip<sup>−/−</sup></i>, and <i>Ciap1<sup>−/−</sup>Ciap2<sup>−/−</sup></i> lethality, suggesting that the TNFR1-mediated endothelial cell death is responsible for some defects during embryogenesis in all of these knockouts<sup><a href="#ref-35">35</a>,<a href="#ref-38">38</a>,<a href="#ref-48">48</a>,<a href="#ref-120">120</a>,<a href="#ref-121">121</a></sup>. It is important to note that deletion of cIAP1 in zebrafish leads to endothelial cell death, implying an evolutionary conservation of the functions of IAPs<sup><a href="#ref-122">122</a></sup>.</p><p class="" id=d29458e1154>Since cIAP1 and 2 ubiquitylate RIPK1, it seemed likely that lethality in IAP knockouts was due to aberrant TNFR1-mediated RIPK1 activation. Surprisingly, <i>Ripk1</i> loss rescued <i>Ciap1<sup>−/−</sup>Ciap2<sup>−/−</sup></i> mice only to E12. Several subsequent reports helped explain why <i>Ripk1</i> loss did not prevent the defects seen in cIAP1/2 double mutants. Within complex II, cleavage of RIPK1 by the caspase-8/cFLIP heterodimers prevents RIPK1 from triggering full processing and activation of caspase-8<sup><a href="#ref-44">44</a></sup>. Furthermore, binding of RIPK1 to RIPK3 via their RHIM domains prevents RIPK3 activation by other RHIM domain-containing proteins such TRIF or DAI<sup><a href="#ref-123">123</a>,<a href="#ref-124">124</a></sup>. This implies that the <i>Ciap1<sup>−/−</sup>Ciap2<sup>−/−</sup>Ripk1<sup>−/−</sup></i> mice might die because of overwhelming caspase-8-dependent apoptosis and RIPK3-dependent necroptosis. Consistent with this idea, mutants lacking the other RIPK1 E3 ligases, <i>Hoil</i> and <i>Hoip</i>, which die at E10 from a cardiac defect similar to that in the <i>Ciap1<sup>−/−</sup>Ciap2<sup>−/−</sup></i> mice, are rescued by co-deletion of genes for RIPK1, RIPK3, and caspase-8<sup><a href="#ref-38">38</a></sup>. Whether the combined absence of RIPK1, RIPK3, and caspase-8 would rescue <i>Ciap1<sup>−/−</sup>Ciap2<sup>−/−</sup></i> double mutants needs to be determined but would show whether cIAP1 and 2 act at the same level as HOIL/HOIP.</p><p class="" id=d29458e1220>Although XIAP deficiency causes primary immunodeficiencies in humans, <i>Xiap<sup>−/−</sup></i> mice are healthy<sup><a href="#ref-113">113</a></sup>. This difference might be due to the fact that environmental factors such as pathogens also play a role in the pathogenesis of human diseases. Accordingly, unchallenged <i>Xiap<sup>−/−</sup></i> mice housed in clean facilities with controlled environments had no phenotype, but when they were challenged with pathogens they developed syndromes resembling those in XIAP-deficient patients, such as splenomegaly and increased cytokine production<sup><a href="#ref-49">49</a>,<a href="#ref-50">50</a>,<a href="#ref-90">90</a>,<a href="#ref-125">125</a></sup>. The role for cIAP1 and 2 in the gut was recently investigated. The authors showed that levels of IAPs were particularly low in enterocytes, consistent with their susceptibility to TNF-induced cell death<sup><a href="#ref-126">126</a></sup>. Whereas responses to TNF were similar in intestinal epithelial cells from wild-type, <i>Xiap<sup>−/−</sup></i>, and <i>Ciap2<sup>−/−</sup></i> mice, those from <i>Ciap1<sup>−/−</sup></i> mice died much more readily, highlighting a critical role for cIAP1 in intestinal homeostasis during infection<sup><a href="#ref-126">126</a></sup>. This implies that although an association of cIAP1 mutations with IBD has not been reported, low levels of cIAP1 might contribute to TNF-mediated enteropathies.</p></div><div class=section><a name=d29458e1275 class=n-a></a><h3 class=section-title>Insights from tissue-specific knockouts</h3><p class="" id=d29458e1280>Tissue-specific IAP knockout mice have provided insights into how IAPs regulate inflammation in particular tissues. For instance, combined deletion of genes for cIAP1 and 2 in the myeloid lineage is sufficient to cause a mild inflammatory phenotype characterized by splenomegaly with disrupted splenic architecture and arthritis<sup><a href="#ref-63">63</a>,<a href="#ref-127">127</a></sup>. Although the loss of both XIAP and cIAP1 in mice did not cause any overt phenotype, the combined loss of both cIAP1/2 and XIAP severely worsened the pathology seen in myeloid-specific <i>Ciap1</i><sup>−/−</sup><i>Ciap2</i><sup>−/−</sup> mice<sup><a href="#ref-63">63</a>,<a href="#ref-127">127</a></sup>. The sterile inflammation was associated with abnormally high levels of cytokines and chemokines in the bloodstream<sup><a href="#ref-63">63</a>,<a href="#ref-127">127</a></sup>. <i>In vitro</i> studies in macrophages revealed that the absence of IAPs leads to the spontaneous production of cytokines, including TNF<sup><a href="#ref-127">127</a></sup>. Furthermore, this cytokine production depended on the presence of both RIPK1 and 3, which subsequently activated apoptosis and necroptosis<sup><a href="#ref-63">63</a>,<a href="#ref-65">65</a>,<a href="#ref-127">127</a></sup>. In addition, lipopolysaccharide challenge of <i>Ciap1</i><sup>−/−</sup><i>Ciap2</i><sup>−/−</sup> macrophages triggered IL-1β secretion and pyroptosis in a RIPK3-dependent manner<sup><a href="#ref-63">63</a>,<a href="#ref-65">65</a></sup>. All together, these findings demonstrated that all three IAPs repress RIPK1/3-mediated cytokine production and cell death. Many other studies have proposed that RIPK1 and 3 control cytokine production in different inflammatory settings, yet the exact molecular mechanisms remain enigmatic<sup><a href="#ref-127">127</a>–<a href="#ref-131">131</a></sup>.</p><p class="" id=d29458e1355>Strikingly, the deletion of both cIAP1 and 2 in the epidermis induced a lethal skin inflammation that occurred in the first week after birth<sup><a href="#ref-132">132</a></sup>. Although the loss of cIAP1 in the skin combined with the loss of XIAP did not induce a lethality, these mice developed skin inflammation in adulthood<sup><a href="#ref-132">132</a></sup>. Similarly, injection of a pan Smac-mimetic into the skin of adult mice led to the development of inflammatory skin lesions<sup><a href="#ref-132">132</a></sup>. These findings highlight a vital role for these proteins in skin development and homeostasis, in which cIAP1 plays a major role. Interestingly, the early lethality of mice lacking both cIAP1 and 2 in the skin phenocopied the effects observed in skin-specific knockout of <i>Fadd</i>, <i>Casp8</i>, <i>Hoil</i>, and <i>Hoip</i><sup><a href="#ref-39">39</a>,<a href="#ref-133">133</a>,<a href="#ref-134">134</a></sup>. All of these skin knockout mice developed epidermal hyperplasia accompanied by the death of keratinocytes and high levels of cytokines in the skin<sup><a href="#ref-132">132</a>–<a href="#ref-134">134</a></sup>. Remarkably, the loss of one allele of <i>Ripk1</i> delayed the death of the <i>Ciap1<sup>−/−</sup>Ciap2<sup>−/−</sup></i> epidermal knockouts to weaning and completely inhibited skin inflammation caused by Smac-mimetic injection<sup><a href="#ref-132">132</a></sup>. Importantly, like the loss of cFLIP in the skin of adult mice, depletion of all IAPs with Smac-mimetic in adult mice led to skin lesions resembling a human inflammatory skin disease called toxic epidermal necrolysis<sup><a href="#ref-132">132</a>,<a href="#ref-135">135</a></sup>. On one hand, an inactivating mutation on the gene encoding the LUBAC component SHARPIN caused a form of dermatitis with features seen in psoriasis and eczema<sup><a href="#ref-136">136</a></sup>. Just as the deletion of one allele of <i>Ripk1</i> greatly reduced the severity of the lesions in skin lacking cIAP1 and 2, it also significantly delayed the <i>Sharpin</i> mutant skin phenotype<sup><a href="#ref-132">132</a></sup>. Importantly, crossing to mice bearing a mutation that inactivated RIPK1’s kinase activity provided a complete rescue of the <i>Sharpin</i> mutant phenotype<sup><a href="#ref-137">137</a></sup>. Collectively, these findings provide the rationale to test RIPK1 inhibitors in inflammatory skin diseases. In this line, GlaxoSmithKline (Brentford, UK) has an ongoing clinical trial testing RIPK1 inhibitors for the treatment of psoriasis (ClinicalTrials.gov Identifier: NCT02776033).</p><p class="" id=d29458e1444>The deletion of genes for cIAP1 and 2 in B cells did not induce lymphocyte cell death but instead provided a survival advantage<sup><a href="#ref-138">138</a></sup>. The accumulation of B cells <i>in vivo</i> was thought to be caused by the activation of the non-canonical NFκB pathway. This pathway is activated by a subset of TNFR members and relies on the stability of the NFκB-inducing kinase (NIK). In cells not exposed to cytokine, the degradation of NIK is triggered by its ubiquitylation by a complex of TRAF2 and 3 and cIAP1 and 2<sup><a href="#ref-56">56</a>,<a href="#ref-139">139</a>–<a href="#ref-142">142</a></sup>. Consistent with this, the mutation or deletion of genes for TRAF2 or 3 or cIAP2 has increased levels of NIK, leading to spontaneous activation of non-canonical NFκB and abnormal accumulation of B cells<sup><a href="#ref-138">138</a>,<a href="#ref-143">143</a>,<a href="#ref-144">144</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29458e1478>Therapeutic interventions targeting IAPs</h2><div class=section><a name=d29458e1481 class=n-a></a><h3 class=section-title>Targeting IAPs to treat inflammatory and infectious diseases</h3><p class="" id=d29458e1486>Activating mutations in NOD2 have been associated with early onset sarcoidosis and Blau syndrome as well as early onset IBD<sup><a href="#ref-145">145</a>,<a href="#ref-146">146</a></sup>. Different strategies have been proposed to target NOD2 signaling to treat these diseases. Several groups showed that kinase inhibitors targeting RIPK2 can inhibit NOD signaling <i>in vitro</i> and <i>in vivo</i> and provide therapeutic responses in mouse models of multiple sclerosis and Crohn’s disease-like ileitis and also in Crohn’s and colitis patient samples<sup><a href="#ref-147">147</a>–<a href="#ref-152">152</a></sup>. The primary assumption was that these kinase inhibitors act by blocking RIPK2’s kinase activity. However, RIPK2 kinase-dead expressing cells had normal responses to NOD stimulation<sup><a href="#ref-88">88</a>,<a href="#ref-152">152</a></sup>. Thus, these inhibitors might act via an allosteric mechanism to interfere with the interaction of RIPK2 with IAPs<sup><a href="#ref-148">148</a>,<a href="#ref-152">152</a></sup>. These studies highlighted the IAP–RIPK2 interaction as a pharmacological target and prompted other researchers to generate XIAP antagonists to disrupt this interaction to block NOD signaling<sup><a href="#ref-88">88</a></sup>. In contrast to pan IAP antagonists, Smac-mimetics that preferentially target XIAP’s BIR2 domain did not induce cell death<sup><a href="#ref-88">88</a></sup>. Instead, these compounds affected XIAP–RIPK2 binding and inhibited NOD2 signaling<sup><a href="#ref-88">88</a></sup>. The promiscuity of many kinase inhibitors compared with the specificity with which the XIAP BIR2 domain regulates NOD signaling<sup><a href="#ref-153">153</a></sup> renders XIAP antagonists particularly attractive for therapeutic intervention. However, given the role for XIAP in limiting IL-1β secretion (see the “Toll-like receptors and inflammasomes” section), it will be important to test the effect of targeting XIAP BIR2 on inflammasome activity.</p><p class="" id=d29458e1540>Suicide of infected cells is one of the strategies that the immune system uses to limit pathogen dissemination and latent reservoirs. Recently, some studies suggested that targeting IAPs could be a therapeutic approach to kill human immunodeficiency virus (HIV)- and hepatitis B virus (HBV)-infected cells. Despite the success of anti-viral therapies, HIV persists because of long-lived, latently infected cells that hide from the immune system. The “shock and kill” treatment strategy consists of re-activating the viral replication of latent virions. The infected cells then would be killed either by the virus itself or by the patient’s immune system. It has been shown that Smac-mimetics can kill long-lived HIV infected CD4<sup>+</sup> T cells or HIV-infected macrophages<sup><a href="#ref-154">154</a>,<a href="#ref-155">155</a></sup>. In addition, one study suggested that the activation of the non-canonical NFκB pathway because of inhibition of cIAP1 and 2 by a Smac-mimetic is able to reactivate the replication of latent viruses<sup><a href="#ref-156">156</a></sup>. Pache <i>et al</i>. showed that the non-canonical transcription factor RELB associates with the viral long terminal repeat to directly influence HIV transcription<sup><a href="#ref-156">156</a></sup>. The combination of a Smac-mimetic and latency-reversing agents can synergistically reverse latency in resting CD4<sup>+</sup> T cells, providing the opportunity for these cells to be attacked by the immune system and/or killed by Smac-mimetics themselves<sup><a href="#ref-156">156</a>,<a href="#ref-157">157</a></sup>. All together, these findings suggest that Smac-mimetics might be used to eliminate latent HIV reservoirs, as they can simultaneously “shock” and “kill” latent infected cells.</p><p class="" id=d29458e1575>Viral latency is also a challenge in HBV infection, as it predisposes to cirrhosis and hepatocellular carcinoma. TNF is an important cytokine promoting HBV clearance<sup><a href="#ref-158">158</a>,<a href="#ref-159">159</a></sup>. Taking advantage of the importance of TNF in HBV, Ebert <i>et al.</i> explored IAP inhibition to switch TNF-induced viral clearance to TNF-induced cell death<sup><a href="#ref-158">158</a>,<a href="#ref-160">160</a></sup>. They found that the deletion of IAP genes or treatment with Smac-mimetics induced early viral clearance<sup><a href="#ref-158">158</a>,<a href="#ref-160">160</a></sup>. IAP inhibition led to cell death of HBV-infected hepatocytes in a TNF-dependent manner with no collateral damage or liver failure. In addition, Smac-mimetics enhanced the efficacy of the standard drug used to treat HBV, entecavir<sup><a href="#ref-158">158</a></sup>. These findings led to a phase I/IIa study of the Smac-mimetic birinapant for the treatment of HBV carriers (ClinicalTrials.gov Identifier: NCT02288208). Unfortunately, this trial had to stop because of temporary cranial nerve palsies observed in the first cohort. This adverse event has also been observed in patients with cancer treated with two Smac-mimetics including birinapant, suggesting that it might not be due to HBV infection<sup><a href="#ref-161">161</a>,<a href="#ref-162">162</a></sup> (ClinicalTrials.gov Identifier: <a target=xrefwindow href="http://clinicaltrials.gov/show/NCT01188499" id=d29458e1613>NCT01188499</a>).</p></div><div class=section><a name=d29458e1618 class=n-a></a><h3 class=section-title>Targeting IAPs to treat cancer</h3><p class="" id=d29458e1623>The ability of IAPs to promote cell survival, and their elevated expression in many cancers, prompted efforts to target them to treat cancers<sup><a href="#ref-163">163</a>,<a href="#ref-164">164</a></sup>. Different approaches were adopted to inhibit IAPs. One was to develop peptidomimetics based on the region of Smac/Diablo that binds to XIAP’s BIR domains, so-called “Smac-mimetics”. Although these drugs were initially designed to target the BIR domains of XIAP because of the similarity to the BIRs of other IAPs, most Smac-mimetics also bind to cIAP1 and 2. It was originally thought that Smac-mimetics would induce cell death because their binding to IAPs would release active caspases in the cytosol. However, their mode of action is mainly via their ability to induce auto-ubiquitylation and degradation of cIAP1 and 2, which leads to activation of the non-canonical NFκB pathway with reduced signals activating canonical NFκB. Although there is no clear experimental proof, it is believed that the non-canonical NFκB pathway is responsible for autocrine TNF secretion. In the absence of cIAP1 and 2, binding of autocrine TNF to TNFR1 triggers the formation of complex II, which kills the cancer cells. To improve the efficacy of Smac-mimetics, several groups used the strategy of combining them with drugs that increase TNF secretion. Cytokines induced by some chemotherapeutic agents would be expected to act synergistically with Smac-mimetics. Similarly, the cytokine storm induced by non-pathologic oncolytic viruses increased Smac-mimetic killing<sup><a href="#ref-165">165</a></sup>. In addition, our group found that p38 inhibitors and caspase inhibitors increased TNF production in response to Smac-mimetics and consequently increased the amount of cell killing<sup><a href="#ref-166">166</a>,<a href="#ref-167">167</a></sup>. Although high levels of TNF can be a safety concern,<b></b>these three combinations were proven to be well tolerated in mice<sup><a href="#ref-165">165</a>–<a href="#ref-167">167</a></sup>.</p><p class="" id=d29458e1653>Mice mutant for IAPs helped determine which IAP would be best to target to find a safe therapeutic window. Targeting all three IAPs is highly inflammatory because it unleashes the inflammatory functions of RIPK1 and 3 which leads to the secretion of not only TNF but also the inflammasome-related cytokines IL-1β and IL-18<sup><a href="#ref-50">50</a>,<a href="#ref-54">54</a>,<a href="#ref-63">63</a>,<a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup>. The inflammatory phenotypes observed in the different IAP mutant mice and cells suggest that an ideal Smac-mimetic should strongly target cIAP1 and less cIAP2 or XIAP or both. This has been exemplified by the comparison of two Smac-mimetics presenting different affinities to each IAP<sup><a href="#ref-168">168</a></sup>. Indeed, the pan Smac-mimetic CompA (K<sub>d</sub> &lt;1 nM for all IAPs) was not tolerated in mice, as it caused widespread severe weight loss and skin lesions<sup><a href="#ref-132">132</a>,<a href="#ref-168">168</a></sup>. In contrast, the Smac-mimetic birinapant, which binds strongly to cIAP1 but has lower affinity for cIAP2 and XIAP, was generally well tolerated in mice and humans<sup><a href="#ref-168">168</a></sup>.</p><p class="" id=d29458e1690>Another issue to consider is the malignancy of cell types that depend on the non-canonical NFκB pathway to survive or to proliferate or both. Like the deletion of genes for cIAP1 and 2 in B cells that caused the proliferation of B cells, the depletion of IAPs by a Smac-mimetic enhanced the survival of B lymphoma cells because of activation of the non-canonical NFκB pathway<sup><a href="#ref-138">138</a>,<a href="#ref-169">169</a></sup>. Nevertheless, this survival advantage is potentially reversed by combining the Smac-mimetic with a proteasome inhibitor<sup><a href="#ref-170">170</a></sup>.</p><p class="" id=d29458e1704>It is unlikely that Smac-mimetics will be used on their own to treat cancer. Several combination treatments have been reported to enhance Smac-mimetic-induced apoptosis and necroptosis<sup><a href="#ref-163">163</a>,<a href="#ref-164">164</a></sup>. Necroptosis has recently emerged as a mechanism to allow killing of cells in which apoptotic pathways are blocked. Combined inhibition of IAPs and caspases triggered necroptosis in leukemia, pancreatic, colorectal, and ovarian cancer cells<sup><a href="#ref-166">166</a>,<a href="#ref-171">171</a>–<a href="#ref-174">174</a></sup>. Consistent with genetic studies, combining a Smac-mimetic with inhibition of caspase-8/cFLIP<sub>L</sub> heterodimers using the clinical caspase inhibitor emricasan strongly triggered necroptosis in leukemic cells<sup><a href="#ref-44">44</a>,<a href="#ref-45">45</a>,<a href="#ref-166">166</a></sup>. Interestingly, in some samples of patients with acute lymphocytic leukemia (ALL), Smac-mimetics alone triggered necroptosis, possibly indicating that some ALL cases do not efficiently activate caspase-8<sup><a href="#ref-175">175</a></sup>. This suggests that Smac-mimetics might provide an alternative treatment for cancers that have silenced caspase-8<sup><a href="#ref-176">176</a></sup>.</p><p class="" id=d29458e1747>Because it is a pro-inflammatory form of cell death, necroptosis can help trigger the immune system to attack cancers in a RIPK1-dependent manner<sup><a href="#ref-177">177</a>,<a href="#ref-178">178</a></sup>. Smac-mimetics have been shown to play a role in anti-tumor immunity in different ways. Because these drugs promote RIPK1 activation, they might promote anti-tumor immunity in part by RIPK1-dependent cytokine production and necroptosis. Accordingly, Smac-mimetics can increase the production of death ligands, IFNγ and IL-2 by immune cells, as well as sensitizing cancer cells to the produced death ligands<sup><a href="#ref-179">179</a>–<a href="#ref-182">182</a></sup>. Smac-mimetics can also enhance cytotoxic lymphocyte killing of tumor cells, decrease expression of the immune checkpoint PD1, polarize M2 macrophages into M1 macrophages, and reduce immunosuppressive T-cell functions<sup><a href="#ref-181">181</a>,<a href="#ref-183">183</a>–<a href="#ref-186">186</a></sup>. In contrast, inhibition of IAPs can increase the expression of the immune checkpoint PDL1, affect memory T cells, and polarize M1 macrophages into M2 macrophages, supporting the invasion and metastasis of tumor cells<sup><a href="#ref-183">183</a>,<a href="#ref-187">187</a>,<a href="#ref-188">188</a></sup>. All together, these finding suggest that Smac-mimetics can act as a double-edged sword in anti-tumor immunity. The challenge now is to determine which combinations are best applied to specific tumor types.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29458e1789>Conclusions</h2><p class="" id=d29458e1792>The generation of IAP mutant mice has offered further insights into how these proteins coordinate innate immune responses. A large body of work has shown that, at the molecular level, IAPs regulate inflammation mainly through the ubiquitylation of RIPK1 and 2. Relatively little is known about other IAP substrates that might play important roles in inflammatory or other signaling pathways. Nevertheless, early findings suggest that IAPs regulate not only the ripoptosome, inflammasome, and apoptosome but also the autophagosome<sup><a href="#ref-189">189</a>,<a href="#ref-190">190</a></sup>. The pleiotropic roles for IAPs mean that Smac-mimetics are not simply “killer drugs” but also induce cytokine production that impacts on immune anti-tumor responses. Although several Smac-mimetics have entered clinical trials to treat cancer and infectious diseases, the identification of molecular and immune biomarkers of response to Smac-mimetics is still lacking.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29458e1805>Abbreviations</h2><p class="" id=d29458e1808>ALL, acute lymphocytic leukemia; BIR, baculoviral repeat domain; cIAP1, cellular inhibitor of apoptosis 1; cIAP2, cellular inhibitor of apoptosis 2; DAMP, damage-associated molecular pattern; EBV, Epstein–Barr virus; HBV, hepatitis B virus; HIV, human immunodeficiency virus; IAP, inhibitor of apoptosis; IBD, inflammatory bowel disease; IFN, interferon; IL, interleukin; LUBAC, linear ubiquitin chain assembly complex; MAPK, mitogen-activated protein kinase; MEF, mouse embryonic fibroblast; NFκB, nuclear factor kappa B; NIK, NFκB-inducing kinase; NLR, NOD-like receptor; NOD, nucleotide-binding oligomerization domain; PAMP, pathogen-associated molecular pattern; RHIM, RIP homotypic interaction motif; RING, really interesting new gene; TLR, Toll-like receptor; TNF, tumor necrosis factor; TNFR1, tumor necrosis factor receptor 1; TRAF, tumor necrosis factor receptor-associated factor; XIAP, X-linked IAP; XLP2, X-linked lymphoproliferative disease 2</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d29458e1 class=n-a></a><h2 class=main-title id=d30053>Grant information</h2><p>This work was supported by project grant #1145588 from the Cancer Australia and Cure Cancer Australia Foundation (to NL), Victorian Cancer Agency Mid-career Fellowship #17030 (to NL), Australian National Health and Medical Research Council (NHMRC) Program Grant #1113133 (to DLV), NHMRC Fellowship #1020136 (to DLV), and Leukemia and Lymphoma Society SCOR grant #7001-13 (to DLV). This work was made possible by operational infrastructure grants through the Australian government’s Independent Research Institute Infrastructure Support Scheme and the Victorian state government’s Operational Infrastructure Support.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d29458e1815 class=n-a></a><h2 class=main-title id=d29458e1817>Acknowledgments</h2><p class="" id=d29458e1820>We apologize to the many people whose work we could not cite here because of space restrictions.</p></div><div class=back-section><a name=d29458e1824 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d30731>References</h2><div class="section ref-list"><a name=d29458e1824 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d29458e1831 class=n-a></a>Crook NE, Clem RJ, Miller LK: An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. <i>J Virol.</i> 1993; <b>67</b>(4): 2168–74. <a target=xrefwindow id=d29458e1839 href="http://www.ncbi.nlm.nih.gov/pubmed/8445726">PubMed Abstract </a> | <a target=xrefwindow id=d29458e1842 href="http://www.ncbi.nlm.nih.gov/pmc/articles/240327">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d29458e1851 class=n-a></a>Birnbaum MJ, Clem RJ, Miller LK: An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs. <i>J Virol.</i> 1994; <b>68</b>(4): 2521–8. <a target=xrefwindow id=d29458e1859 href="http://www.ncbi.nlm.nih.gov/pubmed/8139034">PubMed Abstract </a> | <a target=xrefwindow id=d29458e1862 href="http://www.ncbi.nlm.nih.gov/pmc/articles/236730">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1012589"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e1871 class=n-a></a>Shiozaki EN, Chai J, Rigotti DJ, <i> et al.</i>: Mechanism of XIAP-mediated inhibition of caspase-9. <i>Mol Cell.</i> 2003; <b>11</b>(2): 519–27. <a target=xrefwindow id=d29458e1882 href="http://www.ncbi.nlm.nih.gov/pubmed/12620238">PubMed Abstract </a> | <a target=xrefwindow id=d29458e1885 href="https://doi.org/10.1016/S1097-2765(03)00054-6">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1012589">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d29458e1898 class=n-a></a>Scott FL, Denault JB, Riedl SJ, <i> et al.</i>: XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. <i>EMBO J.</i> 2005; <b>24</b>(3): 645–55. <a target=xrefwindow id=d29458e1909 href="http://www.ncbi.nlm.nih.gov/pubmed/15650747">PubMed Abstract </a> | <a target=xrefwindow id=d29458e1912 href="https://doi.org/10.1038/sj.emboj.7600544">Publisher Full Text </a> | <a target=xrefwindow id=d29458e1916 href="http://www.ncbi.nlm.nih.gov/pmc/articles/548652">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d29458e1925 class=n-a></a>Silke J, Vucic D: IAP family of cell death and signaling regulators. <i>Methods Enzymol.</i> 2014; <b>545</b>: 35–65. <a target=xrefwindow id=d29458e1933 href="http://www.ncbi.nlm.nih.gov/pubmed/25065885">PubMed Abstract </a> | <a target=xrefwindow id=d29458e1936 href="https://doi.org/10.1016/B978-0-12-801430-1.00002-0">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d29458e1946 class=n-a></a>Eckelman BP, Salvesen GS: The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. <i>J Biol Chem.</i> 2006; <b>281</b>(6): 3254–60. <a target=xrefwindow id=d29458e1954 href="http://www.ncbi.nlm.nih.gov/pubmed/16339151">PubMed Abstract </a> | <a target=xrefwindow id=d29458e1957 href="https://doi.org/10.1074/jbc.M510863200">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d29458e1966 class=n-a></a>Rothe M, Pan MG, Henzel WJ, <i> et al.</i>: The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. <i>Cell.</i> 1995; <b>83</b>(7): 1243–52. <a target=xrefwindow id=d29458e1977 href="http://www.ncbi.nlm.nih.gov/pubmed/8548810">PubMed Abstract </a> | <a target=xrefwindow id=d29458e1980 href="https://doi.org/10.1016/0092-8674(95)90149-3">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d29458e1989 class=n-a></a>Samuel T, Welsh K, Lober T, <i> et al.</i>: Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases. <i>J Biol Chem.</i> 2006; <b>281</b>(2): 1080–90. <a target=xrefwindow id=d29458e2000 href="http://www.ncbi.nlm.nih.gov/pubmed/16282325">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2003 href="https://doi.org/10.1074/jbc.M509381200">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d29458e2012 class=n-a></a>Vince JE, Pantaki D, Feltham R, <i> et al.</i>: TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis. <i>J Biol Chem.</i> 2009; <b>284</b>(51): 35906–15. <a target=xrefwindow id=d29458e2023 href="http://www.ncbi.nlm.nih.gov/pubmed/19815541">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2026 href="https://doi.org/10.1074/jbc.M109.072256">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2030 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2791019">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/2952956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2039 class=n-a></a>Zheng C, Kabaleeswaran V, Wang Y, <i> et al.</i>: Crystal structures of the TRAF2: CIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation. <i>Mol Cell.</i> 2010; <b>38</b>(1): 101–13. <a target=xrefwindow id=d29458e2050 href="http://www.ncbi.nlm.nih.gov/pubmed/20385093">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2053 href="https://doi.org/10.1016/j.molcel.2010.03.009">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2057 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2855162">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/2952956">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d29458e2070 class=n-a></a>Annibaldi A, Wicky John S, Vanden Berghe T, <i> et al.</i>: Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2. <i>Mol Cell.</i> 2018; <b>69</b>(4): 566–580.e5. <a target=xrefwindow id=d29458e2081 href="http://www.ncbi.nlm.nih.gov/pubmed/29452637">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2084 href="https://doi.org/10.1016/j.molcel.2018.01.027">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2088 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5823975">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d29458e2098 class=n-a></a>Park S, Hatanpaa KJ, Xie Y, <i> et al.</i>: The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. <i>Cancer Res.</i> 2009; <b>69</b>(7): 2809–16. <a target=xrefwindow id=d29458e2109 href="http://www.ncbi.nlm.nih.gov/pubmed/19339267">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2112 href="https://doi.org/10.1158/0008-5472.CAN-08-4079">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2116 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2859885">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d29458e2125 class=n-a></a>Varfolomeev E, Goncharov T, Fedorova AV, <i> et al.</i>: c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. <i>J Biol Chem.</i> 2008; <b>283</b>(36): 24295–9. <a target=xrefwindow id=d29458e2136 href="http://www.ncbi.nlm.nih.gov/pubmed/18621737">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2139 href="https://doi.org/10.1074/jbc.C800128200">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2143 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3259840">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1123836"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2152 class=n-a></a>Mahoney DJ, Cheung HH, Mrad RL, <i> et al.</i>: Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. <i>Proc Natl Acad Sci U S A.</i> 2008; <b>105</b>(33): 11778–83. <a target=xrefwindow id=d29458e2163 href="http://www.ncbi.nlm.nih.gov/pubmed/18697935">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2166 href="https://doi.org/10.1073/pnas.0711122105">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2170 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2575330">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1123836">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1123956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2183 class=n-a></a>Bertrand MJ, Milutinovic S, Dickson KM, <i> et al.</i>: cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. <i>Mol Cell.</i> 2008; <b>30</b>(6): 689–700. <a target=xrefwindow id=d29458e2194 href="http://www.ncbi.nlm.nih.gov/pubmed/18570872">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2197 href="https://doi.org/10.1016/j.molcel.2008.05.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1123956">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8525956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2210 class=n-a></a>Dynek JN, Goncharov T, Dueber EC, <i> et al.</i>: c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. <i>EMBO J.</i> 2010; <b>29</b>(24): 4198–209. <a target=xrefwindow id=d29458e2221 href="http://www.ncbi.nlm.nih.gov/pubmed/21113135">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2224 href="https://doi.org/10.1038/emboj.2010.300">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2228 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3018797">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8525956">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1145076"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2241 class=n-a></a>Tokunaga F, Sakata S, Saeki Y, <i> et al.</i>: Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. <i>Nat Cell Biol.</i> 2009; <b>11</b>(2): 123–32. <a target=xrefwindow id=d29458e2252 href="http://www.ncbi.nlm.nih.gov/pubmed/19136968">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2255 href="https://doi.org/10.1038/ncb1821">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1145076">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/2248959"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2269 class=n-a></a>Haas TL, Emmerich CH, Gerlach B, <i> et al.</i>: Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. <i>Mol Cell.</i> 2009; <b>36</b>(5): 831–44. <a target=xrefwindow id=d29458e2280 href="http://www.ncbi.nlm.nih.gov/pubmed/20005846">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2283 href="https://doi.org/10.1016/j.molcel.2009.10.013">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/2248959">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13371036"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2296 class=n-a></a>Tokunaga F, Nakagawa T, Nakahara M, <i> et al.</i>: SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. <i>Nature.</i> 2011; <b>471</b>(7340): 633–6. <a target=xrefwindow id=d29458e2307 href="http://www.ncbi.nlm.nih.gov/pubmed/21455180">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2310 href="https://doi.org/10.1038/nature09815">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13371036">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/9451956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2323 class=n-a></a>Gerlach B, Cordier SM, Schmukle AC, <i> et al.</i>: Linear ubiquitination prevents inflammation and regulates immune signalling. <i>Nature.</i> 2011; <b>471</b>(7340): 591–6. <a target=xrefwindow id=d29458e2334 href="http://www.ncbi.nlm.nih.gov/pubmed/21455173">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2337 href="https://doi.org/10.1038/nature09816">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/9451956">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d29458e2350 class=n-a></a>Ikeda F, Deribe YL, Skånland SS, <i> et al.</i>: SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. <i>Nature.</i> 2011; <b>471</b>(7340): 637–41. <a target=xrefwindow id=d29458e2361 href="http://www.ncbi.nlm.nih.gov/pubmed/21455181">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2364 href="https://doi.org/10.1038/nature09814">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2368 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3085511">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d29458e2377 class=n-a></a>Emmerich CH, Bakshi S, Kelsall IR, <i> et al.</i>: Lys63/Met1-hybrid ubiquitin chains are commonly formed during the activation of innate immune signalling. <i>Biochem Biophys Res Commun.</i> 2016; <b>474</b>(3): 452–61. <a target=xrefwindow id=d29458e2388 href="http://www.ncbi.nlm.nih.gov/pubmed/27133719">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2391 href="https://doi.org/10.1016/j.bbrc.2016.04.141">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2395 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4880150">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d29458e2404 class=n-a></a>Kanayama A, Seth RB, Sun L, <i> et al.</i>: TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. <i>Mol Cell.</i> 2004; <b>15</b>(4): 535–48. <a target=xrefwindow id=d29458e2415 href="http://www.ncbi.nlm.nih.gov/pubmed/15327770">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2418 href="https://doi.org/10.1016/j.molcel.2004.08.008">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1032203"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2428 class=n-a></a>Ea CK, Deng L, Xia ZP, <i> et al.</i>: Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. <i>Mol Cell.</i> 2006; <b>22</b>(2): 245–57. <a target=xrefwindow id=d29458e2439 href="http://www.ncbi.nlm.nih.gov/pubmed/16603398">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2442 href="https://doi.org/10.1016/j.molcel.2006.03.026">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1032203">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1031705"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2455 class=n-a></a>Wu CJ, Conze DB, Li T, <i> et al.</i>: Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. <i>Nat Cell Biol.</i> 2006; <b>8</b>(4): 398–406. <a target=xrefwindow id=d29458e2466 href="http://www.ncbi.nlm.nih.gov/pubmed/16547522">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2469 href="https://doi.org/10.1038/ncb1384">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1031705">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d29458e2482 class=n-a></a>Komander D, Reyes-Turcu F, Licchesi JD, <i> et al.</i>: Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. <i>EMBO Rep.</i> 2009; <b>10</b>(5): 466–73. <a target=xrefwindow id=d29458e2493 href="http://www.ncbi.nlm.nih.gov/pubmed/19373254">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2496 href="https://doi.org/10.1038/embor.2009.55">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2500 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2680876">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d29458e2509 class=n-a></a>Rahighi S, Ikeda F, Kawasaki M, <i> et al.</i>: Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. <i>Cell.</i> 2009; <b>136</b>(6): 1098–109. <a target=xrefwindow id=d29458e2520 href="http://www.ncbi.nlm.nih.gov/pubmed/19303852">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2523 href="https://doi.org/10.1016/j.cell.2009.03.007">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1000140"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2532 class=n-a></a>Wang C, Deng L, Hong M, <i> et al.</i>: TAK1 is a ubiquitin-dependent kinase of MKK and IKK. <i>Nature.</i> 2001; <b>412</b>(6844): 346–51. <a target=xrefwindow id=d29458e2543 href="http://www.ncbi.nlm.nih.gov/pubmed/11460167">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2546 href="https://doi.org/10.1038/35085597">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1000140">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d29458e2559 class=n-a></a>Ermolaeva MA, Michallet MC, Papadopoulou N, <i> et al.</i>: Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. <i>Nat Immunol.</i> 2008; <b>9</b>(9): 1037–46. <a target=xrefwindow id=d29458e2570 href="http://www.ncbi.nlm.nih.gov/pubmed/18641654">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2573 href="https://doi.org/10.1038/ni.1638">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d29458e2583 class=n-a></a>Pobezinskaya YL, Kim YS, Choksi S, <i> et al.</i>: The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors. <i>Nat Immunol.</i> 2008; <b>9</b>(9): 1047–54. <a target=xrefwindow id=d29458e2594 href="http://www.ncbi.nlm.nih.gov/pubmed/18641653">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2597 href="https://doi.org/10.1038/ni.1639">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2601 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2577920">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1676956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2610 class=n-a></a>Wong WW, Gentle IE, Nachbur U, <i> et al.</i>: RIPK1 is not essential for TNFR1-induced activation of NF-kappaB. <i>Cell Death Differ.</i> 2010; <b>17</b>(3): 482–7. <a target=xrefwindow id=d29458e2621 href="http://www.ncbi.nlm.nih.gov/pubmed/19927158">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2624 href="https://doi.org/10.1038/cdd.2009.178">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1676956">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d29458e2637 class=n-a></a>Devin A, Cook A, Lin Y, <i> et al.</i>: The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. <i>Immunity.</i> 2000; <b>12</b>(4): 419–29. <a target=xrefwindow id=d29458e2648 href="http://www.ncbi.nlm.nih.gov/pubmed/10795740">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2651 href="https://doi.org/10.1016/S1074-7613(00)80194-6">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d29458e2660 class=n-a></a>Feltham R, Moulin M, Vince JE, <i> et al.</i>: Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding. <i>J Biol Chem.</i> 2010; <b>285</b>(23): 17525–36. <a target=xrefwindow id=d29458e2671 href="http://www.ncbi.nlm.nih.gov/pubmed/20356846">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2674 href="https://doi.org/10.1074/jbc.M109.087635">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2678 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2878517">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d29458e2687 class=n-a></a>Blackwell K, Zhang L, Workman LM, <i> et al.</i>: Two coordinated mechanisms underlie tumor necrosis factor alpha-induced immediate and delayed IκB kinase activation. <i>Mol Cell Biol.</i> 2013; <b>33</b>(10): 1901–15. <a target=xrefwindow id=d29458e2698 href="http://www.ncbi.nlm.nih.gov/pubmed/23459942">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2701 href="https://doi.org/10.1128/MCB.01416-12">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2705 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3647962">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d29458e2714 class=n-a></a>Peltzer N, Rieser E, Taraborrelli L, <i> et al.</i>: HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. <i>Cell Rep.</i> 2014; <b>9</b>(1): 153–65. <a target=xrefwindow id=d29458e2725 href="http://www.ncbi.nlm.nih.gov/pubmed/25284787">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2728 href="https://doi.org/10.1016/j.celrep.2014.08.066">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d29458e2738 class=n-a></a>Draber P, Kupka S, Reichert M, <i> et al.</i>: LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes. <i>Cell Rep.</i> 2015; <b>13</b>(10): 2258–72. <a target=xrefwindow id=d29458e2749 href="http://www.ncbi.nlm.nih.gov/pubmed/26670046">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2752 href="https://doi.org/10.1016/j.celrep.2015.11.009">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2756 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4688036">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d29458e2765 class=n-a></a>Hrdinka M, Fiil BK, Zucca M, <i> et al.</i>: CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling. <i>Cell Rep.</i> 2016; <b>14</b>(12): 2846–58. <a target=xrefwindow id=d29458e2776 href="http://www.ncbi.nlm.nih.gov/pubmed/26997266">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2779 href="https://doi.org/10.1016/j.celrep.2016.02.062">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2783 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4819907">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733107424"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2792 class=n-a></a>Peltzer N, Darding M, Montinaro A, <i> et al.</i>: LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis. <i>Nature.</i> 2018; <b>557</b>(7703): 112–7. <a target=xrefwindow id=d29458e2803 href="http://www.ncbi.nlm.nih.gov/pubmed/29695863">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2806 href="https://doi.org/10.1038/s41586-018-0064-8">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2810 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5947819">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733107424">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734083403"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2823 class=n-a></a>Taraborrelli L, Peltzer N, Montinaro A, <i> et al.</i>: LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L. <i>Nat Commun.</i> 2018; <b>9</b>(1): 3910. <a target=xrefwindow id=d29458e2834 href="http://www.ncbi.nlm.nih.gov/pubmed/30254289">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2837 href="https://doi.org/10.1038/s41467-018-06155-8">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2841 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6156229">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734083403">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1014699"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2854 class=n-a></a>Micheau O, Tschopp J: Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. <i>Cell.</i> 2003; <b>114</b>(2): 181–90. <a target=xrefwindow id=d29458e2862 href="http://www.ncbi.nlm.nih.gov/pubmed/12887920">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2865 href="https://doi.org/10.1016/S0092-8674(03)00521-X">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1014699">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1162205"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2878 class=n-a></a>Cho YS, Challa S, Moquin D, <i> et al.</i>: Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. <i>Cell.</i> 2009; <b>137</b>(6): 1112–23. <a target=xrefwindow id=d29458e2889 href="http://www.ncbi.nlm.nih.gov/pubmed/19524513">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2892 href="https://doi.org/10.1016/j.cell.2009.05.037">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2896 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2727676">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1162205">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d29458e2910 class=n-a></a>Micheau O, Thome M, Schneider P, <i> et al.</i>: The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. <i>J Biol Chem.</i> 2002; <b>277</b>(47): 45162–71. <a target=xrefwindow id=d29458e2921 href="http://www.ncbi.nlm.nih.gov/pubmed/12215447">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2924 href="https://doi.org/10.1074/jbc.M206882200">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d29458e2933 class=n-a></a>Boatright KM, Deis C, Denault JB, <i> et al.</i>: Activation of caspases-8 and -10 by FLIP<sub>L</sub>. <i>Biochem J.</i> 2004; <b>382</b>(Pt 2): 651–7. <a target=xrefwindow id=d29458e2947 href="http://www.ncbi.nlm.nih.gov/pubmed/15209560">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2951 href="https://doi.org/10.1042/BJ20040809">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2954 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1133822">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8885956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e2963 class=n-a></a>Oberst A, Dillon CP, Weinlich R, <i> et al.</i>: Catalytic activity of the caspase-8-FLIP<sub>L</sub> complex inhibits RIPK3-dependent necrosis. <i>Nature.</i> 2011; <b>471</b>(7338): 363–7. <a target=xrefwindow id=d29458e2977 href="http://www.ncbi.nlm.nih.gov/pubmed/21368763">PubMed Abstract </a> | <a target=xrefwindow id=d29458e2981 href="https://doi.org/10.1038/nature09852">Publisher Full Text </a> | <a target=xrefwindow id=d29458e2984 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3077893">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8885956">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d29458e2997 class=n-a></a>Pop C, Oberst A, Drag M, <i> et al.</i>: FLIP<sub>L</sub> induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. <i>Biochem J.</i> 2011; <b>433</b>(3): 447–57. <a target=xrefwindow id=d29458e3011 href="http://www.ncbi.nlm.nih.gov/pubmed/21235526">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3015 href="https://doi.org/10.1042/BJ20101738">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3018 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4024219">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/14267354"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e3027 class=n-a></a>Sun L, Wang H, Wang Z, <i> et al.</i>: Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. <i>Cell.</i> 2012; <b>148</b>(1–2): 213–27. <a target=xrefwindow id=d29458e3038 href="http://www.ncbi.nlm.nih.gov/pubmed/22265413">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3041 href="https://doi.org/10.1016/j.cell.2011.11.031">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/14267354">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d29458e3054 class=n-a></a>Murphy JM, Czabotar PE, Hildebrand JM, <i> et al.</i>: The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. <i>Immunity.</i> 2013; <b>39</b>(3): 443–53. <a target=xrefwindow id=d29458e3065 href="http://www.ncbi.nlm.nih.gov/pubmed/24012422">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3068 href="https://doi.org/10.1016/j.immuni.2013.06.018">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13835961"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e3078 class=n-a></a>Moulin M, Anderton H, Voss AK, <i> et al.</i>: IAPs limit activation of RIP kinases by TNF receptor 1 during development. <i>EMBO J.</i> 2012; <b>31</b>(7): 1679–91. <a target=xrefwindow id=d29458e3089 href="http://www.ncbi.nlm.nih.gov/pubmed/22327219">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3092 href="https://doi.org/10.1038/emboj.2012.18">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3096 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3321198">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13835961">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d29458e3109 class=n-a></a>Prakash H, Albrecht M, Becker D, <i> et al.</i>: Deficiency of XIAP leads to sensitization for <i>Chlamydophila pneumoniae</i> pulmonary infection and dysregulation of innate immune response in mice. <i>J Biol Chem.</i> 2010; <b>285</b>(26): 20291–302. <a target=xrefwindow id=d29458e3123 href="http://www.ncbi.nlm.nih.gov/pubmed/20427267">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3127 href="https://doi.org/10.1074/jbc.M109.096297">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3130 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2888442">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718429930"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e3139 class=n-a></a>Yabal M, Müller N, Adler H, <i> et al.</i>: XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. <i>Cell Rep.</i> 2014; <b>7</b>(6): 1796–808. <a target=xrefwindow id=d29458e3150 href="http://www.ncbi.nlm.nih.gov/pubmed/24882010">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3153 href="https://doi.org/10.1016/j.celrep.2014.05.008">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718429930">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725587410"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e3166 class=n-a></a>de Almagro MC, Goncharov T, Newton K, <i> et al.</i>: Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination. <i>Cell Death Dis.</i> 2015; <b>6</b>: e1800. <a target=xrefwindow id=d29458e3177 href="http://www.ncbi.nlm.nih.gov/pubmed/26111062">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3180 href="https://doi.org/10.1038/cddis.2015.158">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3184 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4669837">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725587410">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d29458e3197 class=n-a></a>Feoktistova M, Geserick P, Kellert B, <i> et al.</i>: cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. <i>Mol Cell.</i> 2011; <b>43</b>(3): 449–63. <a target=xrefwindow id=d29458e3208 href="http://www.ncbi.nlm.nih.gov/pubmed/21737330">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3211 href="https://doi.org/10.1016/j.molcel.2011.06.011">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3215 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3163271">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d29458e3224 class=n-a></a>Tenev T, Bianchi K, Darding M, <i> et al.</i>: The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. <i>Mol Cell.</i> 2011; <b>43</b>(3): 432–48. <a target=xrefwindow id=d29458e3235 href="http://www.ncbi.nlm.nih.gov/pubmed/21737329">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3238 href="https://doi.org/10.1016/j.molcel.2011.06.006">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d29458e3248 class=n-a></a>Lawlor KE, Feltham R, Yabal M, <i> et al.</i>: XIAP Loss Triggers RIPK3- and Caspase-8-Driven IL-1β Activation and Cell Death as a Consequence of TLR-MyD88-Induced cIAP1-TRAF2 Degradation. <i>Cell Rep.</i> 2017; <b>20</b>(3): 668–82. <a target=xrefwindow id=d29458e3259 href="http://www.ncbi.nlm.nih.gov/pubmed/28723569">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3262 href="https://doi.org/10.1016/j.celrep.2017.06.073">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d29458e3271 class=n-a></a>De Nardo D: Toll-like receptors: Activation, signalling and transcriptional modulation. <i>Cytokine.</i> 2015; <b>74</b>(2): 181–9. <a target=xrefwindow id=d29458e3279 href="http://www.ncbi.nlm.nih.gov/pubmed/25846205">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3282 href="https://doi.org/10.1016/j.cyto.2015.02.025">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d29458e3291 class=n-a></a>Vallabhapurapu S, Matsuzawa A, Zhang W, <i> et al.</i>: Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. <i>Nat Immunol.</i> 2008; <b>9</b>(12): 1364–70. <a target=xrefwindow id=d29458e3302 href="http://www.ncbi.nlm.nih.gov/pubmed/18997792">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3305 href="https://doi.org/10.1038/ni.1678">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3309 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2671996">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d29458e3318 class=n-a></a>Xiao Y, Jin J, Chang M, <i> et al.</i>: Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation. <i>Nat Med.</i> 2013; <b>19</b>(5): 595–602. <a target=xrefwindow id=d29458e3329 href="http://www.ncbi.nlm.nih.gov/pubmed/23603814">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3332 href="https://doi.org/10.1038/nm.3111">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3336 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3899792">Free Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d29458e3345 class=n-a></a>Jin J, Xiao Y, Hu H, <i> et al.</i>: Proinflammatory TLR signalling is regulated by a TRAF2-dependent proteolysis mechanism in macrophages. <i>Nat Commun.</i> 2015; <b>6</b>: 5930. <a target=xrefwindow id=d29458e3356 href="http://www.ncbi.nlm.nih.gov/pubmed/25565375">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3359 href="https://doi.org/10.1038/ncomms6930">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3363 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4286812">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d29458e3372 class=n-a></a>Kaiser WJ, Sridharan H, Huang C, <i> et al.</i>: Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. <i>J Biol Chem.</i> 2013; <b>288</b>(43): 31268–79. <a target=xrefwindow id=d29458e3383 href="http://www.ncbi.nlm.nih.gov/pubmed/24019532">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3386 href="https://doi.org/10.1074/jbc.M113.462341">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3390 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3829437">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d29458e3400 class=n-a></a>Weber A, Kirejczyk Z, Besch R, <i> et al.</i>: Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells. <i>Cell Death Differ.</i> 2010; <b>17</b>(6): 942–51. <a target=xrefwindow id=d29458e3411 href="http://www.ncbi.nlm.nih.gov/pubmed/20019748">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3414 href="https://doi.org/10.1038/cdd.2009.190">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d29458e3423 class=n-a></a>Kaiser WJ, Offermann MK: Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. <i>J Immunol.</i> 2005; <b>174</b>(8): 4942–52. <a target=xrefwindow id=d29458e3431 href="http://www.ncbi.nlm.nih.gov/pubmed/15814722">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3434 href="https://doi.org/10.4049/jimmunol.174.8.4942 ">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/723901273"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e3443 class=n-a></a>He S, Liang Y, Shao F, <i> et al.</i>: Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. <i>Proc Natl Acad Sci U S A.</i> 2011; <b>108</b>(50): 20054–9. <a target=xrefwindow id=d29458e3454 href="http://www.ncbi.nlm.nih.gov/pubmed/22123964">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3457 href="https://doi.org/10.1073/pnas.1116302108">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3461 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3250173">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/723901273">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d29458e3474 class=n-a></a>Lawlor KE, Khan N, Mildenhall A, <i> et al.</i>: RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. <i>Nat Commun.</i> 2015; <b>6</b>: 6282. <a target=xrefwindow id=d29458e3485 href="http://www.ncbi.nlm.nih.gov/pubmed/25693118">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3488 href="https://doi.org/10.1038/ncomms7282">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3492 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4346630">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d29458e3501 class=n-a></a>Labbé K, McIntire CR, Doiron K, <i> et al.</i>: Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome. <i>Immunity.</i> 2011; <b>35</b>(6): 897–907. <a target=xrefwindow id=d29458e3512 href="http://www.ncbi.nlm.nih.gov/pubmed/22195745">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3515 href="https://doi.org/10.1016/j.immuni.2011.10.016">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d29458e3524 class=n-a></a>Vince JE, Wong WW, Gentle I, <i> et al.</i>: Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. <i>Immunity.</i> 2012; <b>36</b>(2): 215–27. <a target=xrefwindow id=d29458e3535 href="http://www.ncbi.nlm.nih.gov/pubmed/22365665">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3538 href="https://doi.org/10.1016/j.immuni.2012.01.012">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d29458e3548 class=n-a></a>Wicki S, Gurzeler U, Wei-Lynn Wong W, <i> et al.</i>: Loss of XIAP facilitates switch to TNFα-induced necroptosis in mouse neutrophils. <i>Cell Death Dis.</i> 2016; <b>7</b>(10): e2422. <a target=xrefwindow id=d29458e3559 href="http://www.ncbi.nlm.nih.gov/pubmed/27735938">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3562 href="https://doi.org/10.1038/cddis.2016.311">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3566 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5133978">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d29458e3575 class=n-a></a>Fotin-Mleczek M, Henkler F, Samel D, <i> et al.</i>: Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. <i>J Cell Sci.</i> 2002; <b>115</b>(Pt 13): 2757–70. <a target=xrefwindow id=d29458e3586 href="http://www.ncbi.nlm.nih.gov/pubmed/12077366">PubMed Abstract </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d29458e3595 class=n-a></a>Kenneth NS, Younger JM, Hughes ED, <i> et al.</i>: An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1. <i>Biochem J.</i> 2012; <b>443</b>(2): 355–9. <a target=xrefwindow id=d29458e3606 href="http://www.ncbi.nlm.nih.gov/pubmed/22332634">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3609 href="https://doi.org/10.1042/BJ20120249">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3613 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3327503">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13357258"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e3622 class=n-a></a>Kayagaki N, Warming S, Lamkanfi M, <i> et al.</i>: Non-canonical inflammasome activation targets caspase-11. <i>Nature.</i> 2011; <b>479</b>(7371): 117–21. <a target=xrefwindow id=d29458e3633 href="http://www.ncbi.nlm.nih.gov/pubmed/22002608">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3636 href="https://doi.org/10.1038/nature10558">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13357258">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d29458e3649 class=n-a></a>Maelfait J, Vercammen E, Janssens S, <i> et al.</i>: Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation by caspase-8. <i>J Exp Med.</i> 2008; <b>205</b>(9): 1967–73. <a target=xrefwindow id=d29458e3660 href="http://www.ncbi.nlm.nih.gov/pubmed/18725521">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3663 href="https://doi.org/10.1084/jem.20071632">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3667 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2526192">Free Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d29458e3676 class=n-a></a>Bossaller L, Chiang PI, Schmidt-Lauber C, <i> et al.</i>: Cutting edge: FAS (CD95) mediates noncanonical IL-1β and IL-18 maturation via caspase-8 in an RIP3-independent manner. <i>J Immunol.</i> 2012; <b>189</b>(12): 5508–12. <a target=xrefwindow id=d29458e3687 href="http://www.ncbi.nlm.nih.gov/pubmed/23144495">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3690 href="https://doi.org/10.4049/jimmunol.1202121">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3694 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3518757">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d29458e3704 class=n-a></a>Antonopoulos C, El Sanadi C, Kaiser WJ, <i> et al.</i>: Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1β via caspase-8 in dendritic cells. <i>J Immunol.</i> 2013; <b>191</b>(9): 4789–803. <a target=xrefwindow id=d29458e3715 href="http://www.ncbi.nlm.nih.gov/pubmed/24078693">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3718 href="https://doi.org/10.4049/jimmunol.1300645">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3722 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3870469">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d29458e3731 class=n-a></a>Kang TB, Yang SH, Toth B, <i> et al.</i>: Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. <i>Immunity.</i> 2013; <b>38</b>(1): 27–40. <a target=xrefwindow id=d29458e3742 href="http://www.ncbi.nlm.nih.gov/pubmed/23260196">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3745 href="https://doi.org/10.1016/j.immuni.2012.09.015">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d29458e3754 class=n-a></a>Gurung P, Anand PK, Malireddi RK, <i> et al.</i>: FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. <i>J Immunol.</i> 2014; <b>192</b>(4): 1835–46. <a target=xrefwindow id=d29458e3765 href="http://www.ncbi.nlm.nih.gov/pubmed/24453255">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3768 href="https://doi.org/10.4049/jimmunol.1302839">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3772 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3933570">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d29458e3781 class=n-a></a>Philip NH, Dillon CP, Snyder AG, <i> et al.</i>: Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-κB and MAPK signaling. <i>Proc Natl Acad Sci U S A.</i> 2014; <b>111</b>(20): 7385–90. <a target=xrefwindow id=d29458e3792 href="http://www.ncbi.nlm.nih.gov/pubmed/24799700">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3795 href="https://doi.org/10.1073/pnas.1403252111">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3799 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4034241">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d29458e3808 class=n-a></a>Shenderov K, Riteau N, Yip R, <i> et al.</i>: Cutting edge: Endoplasmic reticulum stress licenses macrophages to produce mature IL-1β in response to TLR4 stimulation through a caspase-8- and TRIF-dependent pathway. <i>J Immunol.</i> 2014; <b>192</b>(5): 2029–33. <a target=xrefwindow id=d29458e3819 href="http://www.ncbi.nlm.nih.gov/pubmed/24489101">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3822 href="https://doi.org/10.4049/jimmunol.1302549">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3826 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3935725">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725364155"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e3835 class=n-a></a>Karki R, Man SM, Malireddi RKS, <i> et al.</i>: Concerted activation of the AIM2 and NLRP3 inflammasomes orchestrates host protection against <i>Aspergillus</i> infection. <i>Cell Host Microbe.</i> 2015; <b>17</b>(3): 357–68. <a target=xrefwindow id=d29458e3849 href="http://www.ncbi.nlm.nih.gov/pubmed/25704009">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3853 href="https://doi.org/10.1016/j.chom.2015.01.006">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3856 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4359672">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725364155">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d29458e3870 class=n-a></a>Andree M, Seeger JM, Schüll S, <i> et al.</i>: BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against <i>Shigella</i>. <i>EMBO J.</i> 2014; <b>33</b>(19): 2171–87. <a target=xrefwindow id=d29458e3884 href="http://www.ncbi.nlm.nih.gov/pubmed/25056906">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3888 href="https://doi.org/10.15252/embj.201387244">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3891 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4282505">Free Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d29458e3900 class=n-a></a>Suzuki S, Suzuki T, Mimuro H, <i> et al.</i>: Shigella hijacks the glomulin-cIAPs-inflammasome axis to promote inflammation. <i>EMBO Rep.</i> 2018; <b>19</b>(1): 89–101. <a target=xrefwindow id=d29458e3911 href="http://www.ncbi.nlm.nih.gov/pubmed/29191979">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3914 href="https://doi.org/10.15252/embr.201643841">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3918 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5757219">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725320475"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e3927 class=n-a></a>Duong BH, Onizawa M, Oses-Prieto JA, <i> et al.</i>: A20 restricts ubiquitination of pro-interleukin-1β protein complexes and suppresses NLRP3 inflammasome activity. <i>Immunity.</i> 2015; <b>42</b>(1): 55–67. <a target=xrefwindow id=d29458e3938 href="http://www.ncbi.nlm.nih.gov/pubmed/25607459">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3941 href="https://doi.org/10.1016/j.immuni.2014.12.031">Publisher Full Text </a> | <a target=xrefwindow id=d29458e3945 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4302274">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725320475">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1162150"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e3958 class=n-a></a>Jin Z, Li Y, Pitti R, <i> et al.</i>: Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. <i>Cell.</i> 2009; <b>137</b>(4): 721–35. <a target=xrefwindow id=d29458e3969 href="http://www.ncbi.nlm.nih.gov/pubmed/19427028">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3972 href="https://doi.org/10.1016/j.cell.2009.03.015">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1162150">F1000 Recommendation</a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d29458e3985 class=n-a></a>Inohara N, Koseki T, Lin J, <i> et al.</i>: An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. <i>J Biol Chem.</i> 2000; <b>275</b>(36): 27823–31. <a target=xrefwindow id=d29458e3996 href="http://www.ncbi.nlm.nih.gov/pubmed/10880512">PubMed Abstract </a> | <a target=xrefwindow id=d29458e3999 href="https://doi.org/10.1074/jbc.M003415200">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d29458e4008 class=n-a></a>Yang Y, Yin C, Pandey A, <i> et al.</i>: NOD2 pathway activation by MDP or <i>Mycobacterium tuberculosis</i> infection involves the stable polyubiquitination of Rip2. <i>J Biol Chem.</i> 2007; <b>282</b>(50): 36223–9. <a target=xrefwindow id=d29458e4022 href="http://www.ncbi.nlm.nih.gov/pubmed/17947236">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4026 href="https://doi.org/10.1074/jbc.M703079200">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d29458e4036 class=n-a></a>Hasegawa M, Fujimoto Y, Lucas PC, <i> et al.</i>: A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. <i>EMBO J.</i> 2008; <b>27</b>(2): 373–83. <a target=xrefwindow id=d29458e4047 href="http://www.ncbi.nlm.nih.gov/pubmed/18079694">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4050 href="https://doi.org/10.1038/sj.emboj.7601962">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4054 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2234345">Free Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d29458e4063 class=n-a></a>Krieg A, Correa RG, Garrison JB, <i> et al.</i>: XIAP mediates NOD signaling via interaction with RIP2. <i>Proc Natl Acad Sci U S A.</i> 2009; <b>106</b>(34): 14524–9. <a target=xrefwindow id=d29458e4074 href="http://www.ncbi.nlm.nih.gov/pubmed/19667203">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4077 href="https://doi.org/10.1073/pnas.0907131106">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4081 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2732880">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d29458e4090 class=n-a></a>Damgaard RB, Fiil BK, Speckmann C, <i> et al.</i>: Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling. <i>EMBO Mol Med.</i> 2013; <b>5</b>(8): 1278–95. <a target=xrefwindow id=d29458e4101 href="http://www.ncbi.nlm.nih.gov/pubmed/23818254">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4104 href="https://doi.org/10.1002/emmm.201303090">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4108 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3944466">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d29458e4117 class=n-a></a>Chirieleison SM, Marsh RA, Kumar P, <i> et al.</i>: Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease. <i>J Biol Chem.</i> 2017; <b>292</b>(23): 9666–79. <a target=xrefwindow id=d29458e4128 href="http://www.ncbi.nlm.nih.gov/pubmed/28404814">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4131 href="https://doi.org/10.1074/jbc.M117.781500">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4135 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5465490">Free Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732691139"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e4144 class=n-a></a>Goncharov T, Hedayati S, Mulvihill MM, <i> et al.</i>: Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling. <i>Mol Cell.</i> 2018; <b>69</b>(4): 551–565.e7. <a target=xrefwindow id=d29458e4155 href="http://www.ncbi.nlm.nih.gov/pubmed/29452636">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4158 href="https://doi.org/10.1016/j.molcel.2018.01.016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732691139">F1000 Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/716597862"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e4171 class=n-a></a>Damgaard RB, Nachbur U, Yabal M, <i> et al.</i>: The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. <i>Mol Cell.</i> 2012; <b>46</b>(6): 746–58. <a target=xrefwindow id=d29458e4182 href="http://www.ncbi.nlm.nih.gov/pubmed/22607974">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4185 href="https://doi.org/10.1016/j.molcel.2012.04.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/716597862">F1000 Recommendation</a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1123020"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e4199 class=n-a></a>Bauler LD, Duckett CS, O'Riordan MX: XIAP regulates cytosol-specific innate immunity to <i>Listeria</i> infection. <i>PLoS Pathog.</i> 2008; <b>4</b>(8): e1000142. <a target=xrefwindow id=d29458e4210 href="http://www.ncbi.nlm.nih.gov/pubmed/18769721">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4213 href="https://doi.org/10.1371/journal.ppat.1000142">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4217 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2516935">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1123020">F1000 Recommendation</a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1028356"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e4230 class=n-a></a>Gesellchen V, Kuttenkeuler D, Steckel M, <i> et al.</i>: An RNA interference screen identifies <i>Inhibitor of Apoptosis Protein 2</i> as a regulator of innate immune signalling in <i>Drosophila</i>. <i>EMBO Rep.</i> 2005; <b>6</b>(10): 979–84. <a target=xrefwindow id=d29458e4248 href="http://www.ncbi.nlm.nih.gov/pubmed/16170305">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4251 href="https://doi.org/10.1038/sj.embor.7400530">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4254 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1369191">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1028356">F1000 Recommendation</a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1028310"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e4267 class=n-a></a>Kleino A, Valanne S, Ulvila J, <i> et al.</i>: Inhibitor of apoptosis 2 and TAK1-binding protein are components of the <i>Drosophila</i> Imd pathway. <i>EMBO J.</i> 2005; <b>24</b>(19): 3423–34. <a target=xrefwindow id=d29458e4281 href="http://www.ncbi.nlm.nih.gov/pubmed/16163390">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4285 href="https://doi.org/10.1038/sj.emboj.7600807">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4288 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1276168">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1028310">F1000 Recommendation</a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d29458e4301 class=n-a></a>Leulier F, Lhocine N, Lemaitre B, <i> et al.</i>: The <i>Drosophila</i> inhibitor of apoptosis protein DIAP2 functions in innate immunity and is essential to resist gram-negative bacterial infection. <i>Mol Cell Biol.</i> 2006; <b>26</b>(21): 7821–31. <a target=xrefwindow id=d29458e4315 href="http://www.ncbi.nlm.nih.gov/pubmed/16894030">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4319 href="https://doi.org/10.1128/MCB.00548-06">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4322 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1636742">Free Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d29458e4331 class=n-a></a>Huh JR, Foe I, Muro I, <i> et al.</i>: The <i>Drosophila</i> inhibitor of apoptosis (IAP) DIAP2 is dispensable for cell survival, required for the innate immune response to gram-negative bacterial infection, and can be negatively regulated by the reaper/hid/grim family of IAP-binding apoptosis inducers. <i>J Biol Chem.</i> 2007; <b>282</b>(3): 2056–68. <a target=xrefwindow id=d29458e4345 href="http://www.ncbi.nlm.nih.gov/pubmed/17068333">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4349 href="https://doi.org/10.1074/jbc.M608051200">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d29458e4358 class=n-a></a>Valanne S, Kleino A, Myllymäki H, <i> et al.</i>: Iap2 is required for a sustained response in the <i>Drosophila</i> Imd pathway. <i>Dev Comp Immunol.</i> 2007; <b>31</b>(10): 991–1001. <a target=xrefwindow id=d29458e4372 href="http://www.ncbi.nlm.nih.gov/pubmed/17343912">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4376 href="https://doi.org/10.1016/j.dci.2007.01.004">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1162076"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e4386 class=n-a></a>Bertrand MJ, Doiron K, Labbé K, <i> et al.</i>: Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. <i>Immunity.</i> 2009; <b>30</b>(6): 789–801. <a target=xrefwindow id=d29458e4397 href="http://www.ncbi.nlm.nih.gov/pubmed/19464198">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4400 href="https://doi.org/10.1016/j.immuni.2009.04.011">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1162076">F1000 Recommendation</a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d29458e4413 class=n-a></a>Bertrand MJ, Lippens S, Staes A, <i> et al.</i>: cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4). <i>PLoS One.</i> 2011; <b>6</b>(9): e22356. <a target=xrefwindow id=d29458e4424 href="http://www.ncbi.nlm.nih.gov/pubmed/21931591">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4427 href="https://doi.org/10.1371/journal.pone.0022356">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4431 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3171409">Free Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732628930"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e4440 class=n-a></a>Stafford CA, Lawlor KE, Heim VJ, <i> et al.</i>: IAPs Regulate Distinct Innate Immune Pathways to Co-ordinate the Response to Bacterial Peptidoglycans. <i>Cell Rep.</i> 2018; <b>22</b>(6): 1496–508. <a target=xrefwindow id=d29458e4451 href="http://www.ncbi.nlm.nih.gov/pubmed/29425505">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4454 href="https://doi.org/10.1016/j.celrep.2018.01.024">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732628930">F1000 Recommendation</a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d29458e4467 class=n-a></a>Aguilar C, Lenoir C, Lambert N, <i> et al.</i>: Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. <i>J Allergy Clin Immunol.</i> 2014; <b>134</b>(5): 1131–41.e9. <a target=xrefwindow id=d29458e4478 href="http://www.ncbi.nlm.nih.gov/pubmed/24942515">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4481 href="https://doi.org/10.1016/j.jaci.2014.04.031">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d29458e4490 class=n-a></a>Christiansen M, Ammann S, Speckmann C, <i> et al.</i>: XIAP deficiency and MEFV variants resulting in an autoinflammatory lymphoproliferative syndrome. <i>BMJ Case Rep.</i> 2016; <b>2016</b>: pii: bcr2016216922. <a target=xrefwindow id=d29458e4501 href="http://www.ncbi.nlm.nih.gov/pubmed/27681353">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4504 href="https://doi.org/10.1136/bcr-2016-216922">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4508 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5051366">Free Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d29458e4517 class=n-a></a>Amininejad L, Charloteaux B, Theatre E, <i> et al.</i>: Analysis of Genes Associated With Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn's Disease. <i>Gastroenterology.</i> 2018; <b>154</b>(8): 2165–77. <a target=xrefwindow id=d29458e4528 href="http://www.ncbi.nlm.nih.gov/pubmed/29501442">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4531 href="https://doi.org/10.1053/j.gastro.2018.02.028">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d29458e4541 class=n-a></a>Latour S, Aguilar C: XIAP deficiency syndrome in humans. <i>Semin Cell Dev Biol.</i> 2015; <b>39</b>: 115–23. <a target=xrefwindow id=d29458e4549 href="http://www.ncbi.nlm.nih.gov/pubmed/25666262">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4552 href="https://doi.org/10.1016/j.semcdb.2015.01.015">Publisher Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1049214"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e4561 class=n-a></a>Rigaud S, Fondanèche MC, Lambert N, <i> et al.</i>: XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. <i>Nature.</i> 2006; <b>444</b>(7115): 110–4. <a target=xrefwindow id=d29458e4572 href="http://www.ncbi.nlm.nih.gov/pubmed/17080092">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4575 href="https://doi.org/10.1038/nature05257">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1049214">F1000 Recommendation</a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d29458e4588 class=n-a></a>Marsh RA, Madden L, Kitchen BJ, <i> et al.</i>: XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. <i>Blood.</i> 2010; <b>116</b>(7): 1079–82. <a target=xrefwindow id=d29458e4599 href="http://www.ncbi.nlm.nih.gov/pubmed/20489057">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4602 href="https://doi.org/10.1182/blood-2010-01-256099">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4606 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2938130">Free Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d29458e4615 class=n-a></a>Pachlopnik Schmid J, Canioni D, Moshous D, <i> et al.</i>: Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). <i>Blood.</i> 2011; <b>117</b>(5): 1522–9. <a target=xrefwindow id=d29458e4626 href="http://www.ncbi.nlm.nih.gov/pubmed/21119115">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4629 href="https://doi.org/10.1182/blood-2010-07-298372">Publisher Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d29458e4638 class=n-a></a>Yang X, Kanegane H, Nishida N, <i> et al.</i>: Clinical and genetic characteristics of XIAP deficiency in Japan. <i>J Clin Immunol.</i> 2012; <b>32</b>(3): 411–20. <a target=xrefwindow id=d29458e4649 href="http://www.ncbi.nlm.nih.gov/pubmed/22228567">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4652 href="https://doi.org/10.1007/s10875-011-9638-z">Publisher Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d29458e4661 class=n-a></a>Speckmann C, Lehmberg K, Albert MH, <i> et al.</i>: X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. <i>Clin Immunol.</i> 2013; <b>149</b>(1): 133–41. <a target=xrefwindow id=d29458e4672 href="http://www.ncbi.nlm.nih.gov/pubmed/23973892">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4675 href="https://doi.org/10.1016/j.clim.2013.07.004">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1001670"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e4685 class=n-a></a>Ogura Y, Bonen DK, Inohara N, <i> et al.</i>: A frameshift mutation in <i>NOD2</i> associated with susceptibility to Crohn's disease. <i>Nature.</i> 2001; <b>411</b>(6837): 603–6. <a target=xrefwindow id=d29458e4699 href="http://www.ncbi.nlm.nih.gov/pubmed/11385577">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4703 href="https://doi.org/10.1038/35079114">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1001670">F1000 Recommendation</a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1000945"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e4716 class=n-a></a>Hugot JP, Chamaillard M, Zouali H, <i> et al.</i>: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. <i>Nature.</i> 2001; <b>411</b>(6837): 599–603. <a target=xrefwindow id=d29458e4727 href="http://www.ncbi.nlm.nih.gov/pubmed/11385576">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4730 href="https://doi.org/10.1038/35079107">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1000945">F1000 Recommendation</a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1165583"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e4743 class=n-a></a>Sabbah A, Chang TH, Harnack R, <i> et al.</i>: Activation of innate immune antiviral responses by Nod2. <i>Nat Immunol.</i> 2009; <b>10</b>(10): 1073–80. <a target=xrefwindow id=d29458e4754 href="http://www.ncbi.nlm.nih.gov/pubmed/19701189">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4757 href="https://doi.org/10.1038/ni.1782">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4761 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2752345">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1165583">F1000 Recommendation</a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d29458e4774 class=n-a></a>Kapoor A, Forman M, Arav-Boger R: Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication. <i>PLoS One.</i> 2014; <b>9</b>(3): e92704. <a target=xrefwindow id=d29458e4782 href="http://www.ncbi.nlm.nih.gov/pubmed/24671169">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4785 href="https://doi.org/10.1371/journal.pone.0092704">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4788 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3966837">Free Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d29458e4797 class=n-a></a>Wada T, Kanegane H, Ohta K, <i> et al.</i>: Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. <i>Cytokine.</i> 2014; <b>65</b>(1): 74–8. <a target=xrefwindow id=d29458e4808 href="http://www.ncbi.nlm.nih.gov/pubmed/24084330">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4811 href="https://doi.org/10.1016/j.cyto.2013.09.007">Publisher Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d29458e4820 class=n-a></a>Harlin H, Reffey SB, Duckett CS, <i> et al.</i>: Characterization of XIAP-deficient mice. <i>Mol Cell Biol.</i> 2001; <b>21</b>(10): 3604–8. <a target=xrefwindow id=d29458e4831 href="http://www.ncbi.nlm.nih.gov/pubmed/11313486">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4834 href="https://doi.org/10.1128/MCB.21.10.3604-3608.2001">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4838 href="http://www.ncbi.nlm.nih.gov/pmc/articles/100282">Free Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d29458e4848 class=n-a></a>Conze DB, Albert L, Ferrick DA, <i> et al.</i>: Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 <i>in vivo</i>. <i>Mol Cell Biol.</i> 2005; <b>25</b>(8): 3348–56. <a target=xrefwindow id=d29458e4862 href="http://www.ncbi.nlm.nih.gov/pubmed/15798218">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4866 href="https://doi.org/10.1128/MCB.25.8.3348-3356.2005">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4869 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1069614">Free Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d29458e4878 class=n-a></a>Heard KN, Bertrand MJ, Barker PA: cIAP2 supports viability of mice lacking cIAP1 and XIAP. <i>EMBO J.</i> 2015; <b>34</b>(19): 2393–5. <a target=xrefwindow id=d29458e4886 href="http://www.ncbi.nlm.nih.gov/pubmed/26427758">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4889 href="https://doi.org/10.15252/embj.201592060">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4892 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4601659">Free Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d29458e4901 class=n-a></a>Moulin M, Voss AK, Thomas T, <i> et al.</i>: Response to Heard <i>et al</i>. <i>EMBO J.</i> 2015; <b>34</b>(19): 2396–7. <a target=xrefwindow id=d29458e4915 href="http://www.ncbi.nlm.nih.gov/pubmed/26427759">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4919 href="https://doi.org/10.15252/embj.201592761">Publisher Full Text </a> | <a target=xrefwindow id=d29458e4922 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4601660">Free Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d29458e4931 class=n-a></a>Varfolomeev EE, Schuchmann M, Luria V, <i> et al.</i>: Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. <i>Immunity.</i> 1998; <b>9</b>(2): 267–76. <a target=xrefwindow id=d29458e4942 href="http://www.ncbi.nlm.nih.gov/pubmed/9729047">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4945 href="https://doi.org/10.1016/S1074-7613(00)80609-3">Publisher Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d29458e4954 class=n-a></a>Yeh WC, de la Pompa JL, McCurrach ME, <i> et al.</i>: FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. <i>Science.</i> 1998; <b>279</b>(5358): 1954–8. <a target=xrefwindow id=d29458e4965 href="http://www.ncbi.nlm.nih.gov/pubmed/9506948">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4968 href="https://doi.org/10.1126/science.279.5358.1954">Publisher Full Text </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d29458e4977 class=n-a></a>Yeh WC, Itie A, Elia AJ, <i> et al.</i>: Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. <i>Immunity.</i> 2000; <b>12</b>(6): 633–42. <a target=xrefwindow id=d29458e4988 href="http://www.ncbi.nlm.nih.gov/pubmed/10894163">PubMed Abstract </a> | <a target=xrefwindow id=d29458e4991 href="https://doi.org/10.1016/S1074-7613(00)80214-9">Publisher Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1020906"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e5001 class=n-a></a>Kang TB, Ben-Moshe T, Varfolomeev EE, <i> et al.</i>: Caspase-8 serves both apoptotic and nonapoptotic roles. <i>J Immunol.</i> 2004; <b>173</b>(5): 2976–84. <a target=xrefwindow id=d29458e5012 href="http://www.ncbi.nlm.nih.gov/pubmed/15322156">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5015 href="https://doi.org/10.4049/jimmunol.173.5.2976">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1020906">F1000 Recommendation</a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718382485"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e5028 class=n-a></a>Dillon CP, Weinlich R, Rodriguez DA, <i> et al.</i>: RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. <i>Cell.</i> 2014; <b>157</b>(5): 1189–202. <a target=xrefwindow id=d29458e5039 href="http://www.ncbi.nlm.nih.gov/pubmed/24813850">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5042 href="https://doi.org/10.1016/j.cell.2014.04.018">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5046 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4068710">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718382485">F1000 Recommendation</a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d29458e5059 class=n-a></a>Santoro MM, Samuel T, Mitchell T, <i> et al.</i>: Birc2 (cIap1) regulates endothelial cell integrity and blood vessel homeostasis. <i>Nat Genet.</i> 2007; <b>39</b>(11): 1397–402. <a target=xrefwindow id=d29458e5070 href="http://www.ncbi.nlm.nih.gov/pubmed/17934460">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5073 href="https://doi.org/10.1038/ng.2007.8">Publisher Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726933836"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e5082 class=n-a></a>Newton K, Wickliffe KE, Maltzman A, <i> et al.</i>: RIPK1 inhibits ZBP1-driven necroptosis during development. <i>Nature.</i> 2016; <b>540</b>(7631): 129–33. <a target=xrefwindow id=d29458e5093 href="http://www.ncbi.nlm.nih.gov/pubmed/27819682">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5096 href="https://doi.org/10.1038/nature20559">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726933836">F1000 Recommendation</a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726933838"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e5109 class=n-a></a>Lin J, Kumari S, Kim C, <i> et al.</i>: RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. <i>Nature.</i> 2016; <b>540</b>(7631): 124–8. <a target=xrefwindow id=d29458e5120 href="http://www.ncbi.nlm.nih.gov/pubmed/27819681">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5123 href="https://doi.org/10.1038/nature20558">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5127 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5755685">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726933838">F1000 Recommendation</a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d29458e5140 class=n-a></a>Hsieh WC, Chuang YT, Chiang IH, <i> et al.</i>: Inability to resolve specific infection generates innate immunodeficiency syndrome in <i>Xiap<sup>-/-</sup></i> mice. <i>Blood.</i> 2014; <b>124</b>(18): 2847–57. <a target=xrefwindow id=d29458e5156 href="http://www.ncbi.nlm.nih.gov/pubmed/25190756">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5160 href="https://doi.org/10.1182/blood-2014-03-564609">Publisher Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727033323"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e5170 class=n-a></a>Grabinger T, Bode KJ, Demgenski J, <i> et al.</i>: Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells. <i>Gastroenterology.</i> 2017; <b>152</b>(4): 867–79. <a target=xrefwindow id=d29458e5181 href="http://www.ncbi.nlm.nih.gov/pubmed/27889570">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5184 href="https://doi.org/10.1053/j.gastro.2016.11.019">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727033323">F1000 Recommendation</a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d29458e5197 class=n-a></a>Wong WW, Vince JE, Lalaoui N, <i> et al.</i>: cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner. <i>Blood.</i> 2014; <b>123</b>(16): 2562–72. <a target=xrefwindow id=d29458e5208 href="http://www.ncbi.nlm.nih.gov/pubmed/24497535">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5211 href="https://doi.org/10.1182/blood-2013-06-510743">Publisher Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d29458e5220 class=n-a></a>Christofferson DE, Li Y, Hitomi J, <i> et al.</i>: A novel role for RIP1 kinase in mediating TNF<i>α</i> production. <i>Cell Death Dis.</i> 2012; <b>3</b>(6): e320. <a target=xrefwindow id=d29458e5234 href="http://www.ncbi.nlm.nih.gov/pubmed/22695613">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5238 href="https://doi.org/10.1038/cddis.2012.64">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5241 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3388236">Free Full Text </a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d29458e5250 class=n-a></a>Lukens JR, Vogel P, Johnson GR, <i> et al.</i>: RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3. <i>Nature.</i> 2013; <b>498</b>(7453): 224–7. <a target=xrefwindow id=d29458e5261 href="http://www.ncbi.nlm.nih.gov/pubmed/23708968">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5264 href="https://doi.org/10.1038/nature12174">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5268 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3683390">Free Full Text </a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d29458e5277 class=n-a></a>Najjar M, Saleh D, Zelic M, <i> et al.</i>: RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4. <i>Immunity.</i> 2016; <b>45</b>(1): 46–59. <a target=xrefwindow id=d29458e5288 href="http://www.ncbi.nlm.nih.gov/pubmed/27396959">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5291 href="https://doi.org/10.1016/j.immuni.2016.06.007">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5295 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4956514">Free Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d29458e5304 class=n-a></a>Kang TB, Jeong JS, Yang SH, <i> et al.</i>: Caspase-8 deficiency in mouse embryos triggers chronic RIPK1-dependent activation of inflammatory genes, independently of RIPK3. <i>Cell Death Differ.</i> 2018; <b>25</b>(6): 1107–17. <a target=xrefwindow id=d29458e5315 href="http://www.ncbi.nlm.nih.gov/pubmed/29666472">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5318 href="https://doi.org/10.1038/s41418-018-0104-9">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5322 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5988659">Free Full Text </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d29458e5332 class=n-a></a>Anderton H, Rickard JA, Varigos GA, <i> et al.</i>: Inhibitor of Apoptosis Proteins (IAPs) Limit RIPK1-Mediated Skin Inflammation. <i>J Invest Dermatol.</i> 2017; <b>137</b>(11): 2371–9. <a target=xrefwindow id=d29458e5343 href="http://www.ncbi.nlm.nih.gov/pubmed/28647349">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5346 href="https://doi.org/10.1016/j.jid.2017.05.031">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d29458e5355 class=n-a></a>Kovalenko A, Kim JC, Kang TB, <i> et al.</i>: Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. <i>J Exp Med.</i> 2009; <b>206</b>(10): 2161–77. <a target=xrefwindow id=d29458e5366 href="http://www.ncbi.nlm.nih.gov/pubmed/19720838">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5369 href="https://doi.org/10.1084/jem.20090616">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5373 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2757876">Free Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13485052"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e5382 class=n-a></a>Bonnet MC, Preukschat D, Welz PS, <i> et al.</i>: The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. <i>Immunity.</i> 2011; <b>35</b>(4): 572–82. <a target=xrefwindow id=d29458e5393 href="http://www.ncbi.nlm.nih.gov/pubmed/22000287">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5396 href="https://doi.org/10.1016/j.immuni.2011.08.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13485052">F1000 Recommendation</a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d29458e5409 class=n-a></a>Panayotova-Dimitrova D, Feoktistova M, Ploesser M, <i> et al.</i>: cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis. <i>Cell Rep.</i> 2013; <b>5</b>(2): 397–408. <a target=xrefwindow id=d29458e5420 href="http://www.ncbi.nlm.nih.gov/pubmed/24209745">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5423 href="https://doi.org/10.1016/j.celrep.2013.09.035">Publisher Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d29458e5432 class=n-a></a>HogenEsch H, Gijbels MJ, Offerman E, <i> et al.</i>: A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. <i>Am J Pathol.</i> 1993; <b>143</b>(3): 972–82. <a target=xrefwindow id=d29458e5443 href="http://www.ncbi.nlm.nih.gov/pubmed/8362989">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5446 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1887192">Free Full Text </a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a name=d29458e5455 class=n-a></a>Berger SB, Kasparcova V, Hoffman S, <i> et al.</i>: Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. <i>J Immunol.</i> 2014; <b>192</b>(12): 5476–80. <a target=xrefwindow id=d29458e5466 href="http://www.ncbi.nlm.nih.gov/pubmed/24821972">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5469 href="https://doi.org/10.4049/jimmunol.1400499">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5473 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4048763">Free Full Text </a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a name=d29458e5483 class=n-a></a>Gardam S, Turner VM, Anderton H, <i> et al.</i>: Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. <i>Blood.</i> 2011; <b>117</b>(15): 4041–51. <a target=xrefwindow id=d29458e5494 href="http://www.ncbi.nlm.nih.gov/pubmed/21300983">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5497 href="https://doi.org/10.1182/blood-2010-10-312793">Publisher Full Text </a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a name=d29458e5506 class=n-a></a>Liao G, Zhang M, Harhaj EW, <i> et al.</i>: Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. <i>J Biol Chem.</i> 2004; <b>279</b>(25): 26243–50. <a target=xrefwindow id=d29458e5517 href="http://www.ncbi.nlm.nih.gov/pubmed/15084608">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5520 href="https://doi.org/10.1074/jbc.M403286200">Publisher Full Text </a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a name=d29458e5529 class=n-a></a>He JQ, Saha SK, Kang JR, <i> et al.</i>: Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway. <i>J Biol Chem.</i> 2007; <b>282</b>(6): 3688–94. <a target=xrefwindow id=d29458e5540 href="http://www.ncbi.nlm.nih.gov/pubmed/17158868">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5543 href="https://doi.org/10.1074/jbc.M610271200">Publisher Full Text </a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a name=d29458e5552 class=n-a></a>Zarnegar BJ, Wang Y, Mahoney DJ, <i> et al.</i>: Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. <i>Nat Immunol.</i> 2008; <b>9</b>(12): 1371–8. <a target=xrefwindow id=d29458e5563 href="http://www.ncbi.nlm.nih.gov/pubmed/18997794">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5566 href="https://doi.org/10.1038/ni.1676">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5570 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2676931">Free Full Text </a></span></li><li><a name=ref-142 class=n-a></a><span class=label>142. </span>&nbsp;<span class=citation><a name=d29458e5579 class=n-a></a>Lee S, Challa-Malladi M, Bratton SB, <i> et al.</i>: Nuclear factor-κB-inducing kinase (NIK) contains an amino-terminal inhibitor of apoptosis (IAP)-binding motif (IBM) that potentiates NIK degradation by cellular IAP1 (c-IAP1). <i>J Biol Chem.</i> 2014; <b>289</b>(44): 30680–9. <a target=xrefwindow id=d29458e5590 href="http://www.ncbi.nlm.nih.gov/pubmed/25246529">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5593 href="https://doi.org/10.1074/jbc.M114.587808">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5597 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4215246">Free Full Text </a></span></li><li><a name=ref-143 class=n-a></a><span class=label>143. </span>&nbsp;<span class=citation><a name=d29458e5606 class=n-a></a>Grech AP, Amesbury M, Chan T, <i> et al.</i>: TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. <i>Immunity.</i> 2004; <b>21</b>(5): 629–42. <a target=xrefwindow id=d29458e5617 href="http://www.ncbi.nlm.nih.gov/pubmed/15539150">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5620 href="https://doi.org/10.1016/j.immuni.2004.09.011">Publisher Full Text </a></span></li><li><a name=ref-144 class=n-a></a><span class=label>144. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/11734956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e5630 class=n-a></a>Conze DB, Zhao Y, Ashwell JD: Non-canonical NF-κB activation and abnormal B cell accumulation in mice expressing ubiquitin protein ligase-inactive c-IAP2. <i>PLoS Biol.</i> 2010; <b>8</b>(10): e1000518. <a target=xrefwindow id=d29458e5638 href="http://www.ncbi.nlm.nih.gov/pubmed/21048983">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5641 href="https://doi.org/10.1371/journal.pbio.1000518">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5644 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2964333">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/11734956">F1000 Recommendation</a></span></li><li><a name=ref-145 class=n-a></a><span class=label>145. </span>&nbsp;<span class=citation><a name=d29458e5657 class=n-a></a>Uhlig HH, Schwerd T: From Genes to Mechanisms: The Expanding Spectrum of Monogenic Disorders Associated with Inflammatory Bowel Disease. <i>Inflamm Bowel Dis.</i> 2016; <b>22</b>(1): 202–12. <a target=xrefwindow id=d29458e5665 href="http://www.ncbi.nlm.nih.gov/pubmed/26512716">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5668 href="https://doi.org/10.1097/MIB.0000000000000614">Publisher Full Text </a></span></li><li><a name=ref-146 class=n-a></a><span class=label>146. </span>&nbsp;<span class=citation><a name=d29458e5677 class=n-a></a>Negroni A, Pierdomenico M, Cucchiara S, <i> et al.</i>: NOD2 and inflammation: current insights. <i>J Inflamm Res.</i> 2018; <b>11</b>: 49–60. <a target=xrefwindow id=d29458e5688 href="http://www.ncbi.nlm.nih.gov/pubmed/29483781">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5691 href="https://doi.org/10.2147/JIR.S137606">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5695 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5813767">Free Full Text </a></span></li><li><a name=ref-147 class=n-a></a><span class=label>147. </span>&nbsp;<span class=citation><a name=d29458e5704 class=n-a></a>Shaw PJ, Barr MJ, Lukens JR, <i> et al.</i>: Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity. <i>Immunity.</i> 2011; <b>34</b>(1): 75–84. <a target=xrefwindow id=d29458e5715 href="http://www.ncbi.nlm.nih.gov/pubmed/21236705">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5718 href="https://doi.org/10.1016/j.immuni.2010.12.015">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5722 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3057380">Free Full Text </a></span></li><li><a name=ref-148 class=n-a></a><span class=label>148. </span>&nbsp;<span class=citation><a name=d29458e5731 class=n-a></a>Nachbur U, Stafford CA, Bankovacki A, <i> et al.</i>: A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production. <i>Nat Commun.</i> 2015; <b>6</b>: 6442. <a target=xrefwindow id=d29458e5742 href="http://www.ncbi.nlm.nih.gov/pubmed/25778803">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5745 href="https://doi.org/10.1038/ncomms7442">Publisher Full Text </a></span></li><li><a name=ref-149 class=n-a></a><span class=label>149. </span>&nbsp;<span class=citation><a name=d29458e5754 class=n-a></a>Canning P, Ruan Q, Schwerd T, <i> et al.</i>: Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors. <i>Chem Biol.</i> 2015; <b>22</b>(9): 1174–84. <a target=xrefwindow id=d29458e5765 href="http://www.ncbi.nlm.nih.gov/pubmed/26320862">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5768 href="https://doi.org/10.1016/j.chembiol.2015.07.017">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5772 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4579271">Free Full Text </a></span></li><li><a name=ref-150 class=n-a></a><span class=label>150. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726310483"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e5782 class=n-a></a>Haile PA, Votta BJ, Marquis RW, <i> et al.</i>: The Identification and Pharmacological Characterization of 6-(<i>tert</i>-Butylsulfonyl)-<i>N</i>-(5-fluoro-1<i>H</i>-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase. <i>J Med Chem.</i> 2016; <b>59</b>(10): 4867–80. <a target=xrefwindow id=d29458e5803 href="http://www.ncbi.nlm.nih.gov/pubmed/27109867">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5806 href="https://doi.org/10.1021/acs.jmedchem.6b00211">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726310483">F1000 Recommendation</a></span></li><li><a name=ref-151 class=n-a></a><span class=label>151. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731797763"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e5819 class=n-a></a>He X, Da Ros S, Nelson J, <i> et al.</i>: Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases. <i>ACS Med Chem Lett.</i> 2017; <b>8</b>(10): 1048–53. <a target=xrefwindow id=d29458e5830 href="http://www.ncbi.nlm.nih.gov/pubmed/29057049">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5833 href="https://doi.org/10.1021/acsmedchemlett.7b00258">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5837 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5641954">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731797763">F1000 Recommendation</a></span></li><li><a name=ref-152 class=n-a></a><span class=label>152. </span>&nbsp;<span class=citation><a name=d29458e5850 class=n-a></a>Hrdinka M, Schlicher L, Dai B, <i> et al.</i>: Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling. <i>EMBO J.</i> 2018; <b>37</b>(17): pii: e99372. <a target=xrefwindow id=d29458e5861 href="http://www.ncbi.nlm.nih.gov/pubmed/30026309">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5864 href="https://doi.org/10.15252/embj.201899372">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5868 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6120666">Free Full Text </a></span></li><li><a name=ref-153 class=n-a></a><span class=label>153. </span>&nbsp;<span class=citation><a name=d29458e5877 class=n-a></a>Chirieleison SM, Rathkey JK, Abbott DW: Unique BIR domain sets determine inhibitor of apoptosis protein-driven cell death and NOD2 complex signal specificity. <i>Sci Signal.</i> 2018; <b>11</b>(539): pii: eaao3964. <a target=xrefwindow id=d29458e5885 href="http://www.ncbi.nlm.nih.gov/pubmed/30018081">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5888 href="https://doi.org/10.1126/scisignal.aao3964">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5891 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6066185">Free Full Text </a></span></li><li><a name=ref-154 class=n-a></a><span class=label>154. </span>&nbsp;<span class=citation><a name=d29458e5900 class=n-a></a>Busca A, Saxena M, Kumar A: Critical role for antiapoptotic Bcl-xL and Mcl-1 in human macrophage survival and cellular IAP1/2 (cIAP1/2) in resistance to HIV-Vpr-induced apoptosis. <i>J Biol Chem.</i> 2012; <b>287</b>(18): 15118–33. <a target=xrefwindow id=d29458e5908 href="http://www.ncbi.nlm.nih.gov/pubmed/22403404">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5911 href="https://doi.org/10.1074/jbc.M111.312660">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5914 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3340279">Free Full Text </a></span></li><li><a name=ref-155 class=n-a></a><span class=label>155. </span>&nbsp;<span class=citation><a name=d29458e5923 class=n-a></a>Campbell GR, Bruckman RS, Chu YL, <i> et al.</i>: SMAC Mimetics Induce Autophagy-Dependent Apoptosis of HIV-1-Infected Resting Memory CD4+ T Cells. <i>Cell Host Microbe.</i> 2018; <b>24</b>(5): 689–702.e7. <a target=xrefwindow id=d29458e5934 href="http://www.ncbi.nlm.nih.gov/pubmed/30344003">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5937 href="https://doi.org/10.1016/j.chom.2018.09.007">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5941 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6250054">Free Full Text </a></span></li><li><a name=ref-156 class=n-a></a><span class=label>156. </span>&nbsp;<span class=citation><a name=d29458e5951 class=n-a></a>Pache L, Dutra MS, Spivak AM, <i> et al.</i>: BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency. <i>Cell Host Microbe.</i> 2015; <b>18</b>(3): 345–53. <a target=xrefwindow id=d29458e5962 href="http://www.ncbi.nlm.nih.gov/pubmed/26355217">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5965 href="https://doi.org/10.1016/j.chom.2015.08.009">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5969 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4617541">Free Full Text </a></span></li><li><a name=ref-157 class=n-a></a><span class=label>157. </span>&nbsp;<span class=citation><a name=d29458e5978 class=n-a></a>Hattori SI, Matsuda K, Tsuchiya K, <i> et al.</i>: Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection <i>in vitro</i>. <i>Front Microbiol.</i> 2018; <b>9</b>: 2022. <a target=xrefwindow id=d29458e5992 href="http://www.ncbi.nlm.nih.gov/pubmed/30283406">PubMed Abstract </a> | <a target=xrefwindow id=d29458e5996 href="https://doi.org/10.3389/fmicb.2018.02022">Publisher Full Text </a> | <a target=xrefwindow id=d29458e5999 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6156138">Free Full Text </a></span></li><li><a name=ref-158 class=n-a></a><span class=label>158. </span>&nbsp;<span class=citation><a name=d29458e6008 class=n-a></a>Ebert G, Preston S, Allison C, <i> et al.</i>: Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. <i>Proc Natl Acad Sci U S A.</i> 2015; <b>112</b>(18): 5797–802. <a target=xrefwindow id=d29458e6019 href="http://www.ncbi.nlm.nih.gov/pubmed/25902529">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6022 href="https://doi.org/10.1073/pnas.1502390112">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6026 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4426461">Free Full Text </a></span></li><li><a name=ref-159 class=n-a></a><span class=label>159. </span>&nbsp;<span class=citation><a name=d29458e6035 class=n-a></a>Yang PL, Althage A, Chung J, <i> et al.</i>: Immune effectors required for hepatitis B virus clearance. <i>Proc Natl Acad Sci U S A.</i> 2010; <b>107</b>(2): 798–802. <a target=xrefwindow id=d29458e6046 href="http://www.ncbi.nlm.nih.gov/pubmed/20080755">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6049 href="https://doi.org/10.1073/pnas.0913498107">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6053 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2818933">Free Full Text </a></span></li><li><a name=ref-160 class=n-a></a><span class=label>160. </span>&nbsp;<span class=citation><a name=d29458e6062 class=n-a></a>Ebert G, Allison C, Preston S, <i> et al.</i>: Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis. <i>Proc Natl Acad Sci U S A.</i> 2015; <b>112</b>(18): 5803–8. <a target=xrefwindow id=d29458e6073 href="http://www.ncbi.nlm.nih.gov/pubmed/25902530">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6076 href="https://doi.org/10.1073/pnas.1502400112">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6080 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4426438">Free Full Text </a></span></li><li><a name=ref-161 class=n-a></a><span class=label>161. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725767047"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e6089 class=n-a></a>Amaravadi RK, Schilder RJ, Martin LP, <i> et al.</i>: A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma. <i>Mol Cancer Ther.</i> 2015; <b>14</b>(11): 2569–75. <a target=xrefwindow id=d29458e6100 href="http://www.ncbi.nlm.nih.gov/pubmed/26333381">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6103 href="https://doi.org/10.1158/1535-7163.MCT-15-0475">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725767047">F1000 Recommendation</a></span></li><li><a name=ref-162 class=n-a></a><span class=label>162. </span>&nbsp;<span class=citation><a name=d29458e6117 class=n-a></a>Noonan AM, Bunch KP, Chen JQ, <i> et al.</i>: Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer. <i>Cancer.</i> 2016; <b>122</b>(4): 588–97. <a target=xrefwindow id=d29458e6128 href="http://www.ncbi.nlm.nih.gov/pubmed/26566079">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6131 href="https://doi.org/10.1002/cncr.29783">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6135 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4742409">Free Full Text </a></span></li><li><a name=ref-163 class=n-a></a><span class=label>163. </span>&nbsp;<span class=citation><a name=d29458e6144 class=n-a></a>Fulda S: Smac mimetics as IAP antagonists. <i>Semin Cell Dev Biol.</i> 2015; <b>39</b>: 132–8. <a target=xrefwindow id=d29458e6152 href="http://www.ncbi.nlm.nih.gov/pubmed/25550219">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6155 href="https://doi.org/10.1016/j.semcdb.2014.12.005">Publisher Full Text </a></span></li><li><a name=ref-164 class=n-a></a><span class=label>164. </span>&nbsp;<span class=citation><a name=d29458e6164 class=n-a></a>Fulda S: Smac Mimetics to Therapeutically Target IAP Proteins in Cancer. <i>Int Rev Cell Mol Biol.</i> 2017; <b>330</b>: 157–69. <a target=xrefwindow id=d29458e6172 href="http://www.ncbi.nlm.nih.gov/pubmed/28215531">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6175 href="https://doi.org/10.1016/bs.ircmb.2016.09.004">Publisher Full Text </a></span></li><li><a name=ref-165 class=n-a></a><span class=label>165. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718252429"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e6184 class=n-a></a>Beug ST, Tang VA, LaCasse EC, <i> et al.</i>: Smac mimetics and innate immune stimuli synergize to promote tumor death. <i>Nat Biotechnol.</i> 2014; <b>32</b>(2): 182–90. <a target=xrefwindow id=d29458e6195 href="http://www.ncbi.nlm.nih.gov/pubmed/24463573">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6198 href="https://doi.org/10.1038/nbt.2806">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6202 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5030098">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718252429">F1000 Recommendation</a></span></li><li><a name=ref-166 class=n-a></a><span class=label>166. </span>&nbsp;<span class=citation><a name=d29458e6215 class=n-a></a>Brumatti G, Ma C, Lalaoui N, <i> et al.</i>: The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia. <i>Sci Transl Med.</i> 2016; <b>8</b>(339): 339ra69. <a target=xrefwindow id=d29458e6226 href="http://www.ncbi.nlm.nih.gov/pubmed/27194727">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6229 href="https://doi.org/10.1126/scitranslmed.aad3099">Publisher Full Text </a></span></li><li><a name=ref-167 class=n-a></a><span class=label>167. </span>&nbsp;<span class=citation><a name=d29458e6238 class=n-a></a>Lalaoui N, Hänggi K, Brumatti G, <i> et al.</i>: Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics. <i>Cancer Cell.</i> 2016; <b>29</b>(2): 145–58. <a target=xrefwindow id=d29458e6249 href="http://www.ncbi.nlm.nih.gov/pubmed/26859455">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6252 href="https://doi.org/10.1016/j.ccell.2016.01.006">Publisher Full Text </a></span></li><li><a name=ref-168 class=n-a></a><span class=label>168. </span>&nbsp;<span class=citation><a name=d29458e6262 class=n-a></a>Condon SM, Mitsuuchi Y, Deng Y, <i> et al.</i>: Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignancies. <i>J Med Chem.</i> 2014; <b>57</b>(9): 3666–77. <a target=xrefwindow id=d29458e6273 href="http://www.ncbi.nlm.nih.gov/pubmed/24684347">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6276 href="https://doi.org/10.1021/jm500176w">Publisher Full Text </a></span></li><li><a name=ref-169 class=n-a></a><span class=label>169. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726269028"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e6285 class=n-a></a>West AC, Martin BP, Andrews DA, <i> et al.</i>: The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock. <i>Oncogenesis.</i> 2016; <b>5</b>: e216. <a target=xrefwindow id=d29458e6296 href="http://www.ncbi.nlm.nih.gov/pubmed/27043662">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6299 href="https://doi.org/10.1038/oncsis.2016.26">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6303 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4848837">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726269028">F1000 Recommendation</a></span></li><li><a name=ref-170 class=n-a></a><span class=label>170. </span>&nbsp;<span class=citation><a name=d29458e6316 class=n-a></a>Bhatti IA, Abhari BA, Fulda S: Identification of a synergistic combination of Smac mimetic and Bortezomib to trigger cell death in B-cell non-Hodgkin lymphoma cells. <i>Cancer Lett.</i> 2017; <b>405</b>: 63–72. <a target=xrefwindow id=d29458e6324 href="http://www.ncbi.nlm.nih.gov/pubmed/28716527">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6327 href="https://doi.org/10.1016/j.canlet.2017.07.008">Publisher Full Text </a></span></li><li><a name=ref-171 class=n-a></a><span class=label>171. </span>&nbsp;<span class=citation><a name=d29458e6336 class=n-a></a>McCabe KE, Bacos K, Lu D, <i> et al.</i>: Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma. <i>Cell Death Dis.</i> 2014; <b>5</b>: e1496. <a target=xrefwindow id=d29458e6347 href="http://www.ncbi.nlm.nih.gov/pubmed/25356865">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6350 href="https://doi.org/10.1038/cddis.2014.448">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6354 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4237265">Free Full Text </a></span></li><li><a name=ref-172 class=n-a></a><span class=label>172. </span>&nbsp;<span class=citation><a name=d29458e6363 class=n-a></a>Hannes S, Abhari BA, Fulda S: Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked. <i>Cancer Lett.</i> 2016; <b>380</b>(1): 31–8. <a target=xrefwindow id=d29458e6371 href="http://www.ncbi.nlm.nih.gov/pubmed/27267809">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6374 href="https://doi.org/10.1016/j.canlet.2016.05.036">Publisher Full Text </a></span></li><li><a name=ref-173 class=n-a></a><span class=label>173. </span>&nbsp;<span class=citation><a name=d29458e6383 class=n-a></a>Safferthal C, Rohde K, Fulda S: Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells. <i>Oncogene.</i> 2017; <b>36</b>(11): 1487–502. <a target=xrefwindow id=d29458e6391 href="http://www.ncbi.nlm.nih.gov/pubmed/27869161">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6394 href="https://doi.org/10.1038/onc.2016.310">Publisher Full Text </a></span></li><li><a name=ref-174 class=n-a></a><span class=label>174. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727590758"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e6404 class=n-a></a>He GW, Günther C, Thonn V, <i> et al.</i>: Regression of apoptosis-resistant colorectal tumors by induction of necroptosis in mice. <i>J Exp Med.</i> 2017; <b>214</b>(6): 1655–62. <a target=xrefwindow id=d29458e6415 href="http://www.ncbi.nlm.nih.gov/pubmed/28476895">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6418 href="https://doi.org/10.1084/jem.20160442">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6422 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5460989">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727590758">F1000 Recommendation</a></span></li><li><a name=ref-175 class=n-a></a><span class=label>175. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726365896"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e6435 class=n-a></a>McComb S, Aguadé-Gorgorió J, Harder L, <i> et al.</i>: Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL. <i>Sci Transl Med.</i> 2016; <b>8</b>(339): 339ra70. <a target=xrefwindow id=d29458e6446 href="http://www.ncbi.nlm.nih.gov/pubmed/27194728">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6449 href="https://doi.org/10.1126/scitranslmed.aad2986">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726365896">F1000 Recommendation</a></span></li><li><a name=ref-176 class=n-a></a><span class=label>176. </span>&nbsp;<span class=citation><a name=d29458e6462 class=n-a></a>Stupack DG: Caspase-8 as a therapeutic target in cancer. <i>Cancer Lett.</i> 2013; <b>332</b>(2): 133–40. <a target=xrefwindow id=d29458e6470 href="http://www.ncbi.nlm.nih.gov/pubmed/20817393">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6473 href="https://doi.org/10.1016/j.canlet.2010.07.022">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6476 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3049203">Free Full Text </a></span></li><li><a name=ref-177 class=n-a></a><span class=label>177. </span>&nbsp;<span class=citation><a name=d29458e6485 class=n-a></a>Yatim N, Jusforgues-Saklani H, Orozco S, <i> et al.</i>: RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8<sup>+</sup> T cells. <i>Science.</i> 2015; <b>350</b>(6258): 328–34. <a target=xrefwindow id=d29458e6499 href="http://www.ncbi.nlm.nih.gov/pubmed/26405229">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6503 href="https://doi.org/10.1126/science.aad0395">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6506 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4651449">Free Full Text </a></span></li><li><a name=ref-178 class=n-a></a><span class=label>178. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726267982"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e6515 class=n-a></a>Aaes TL, Kaczmarek A, Delvaeye T, <i> et al.</i>: Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity. <i>Cell Rep.</i> 2016; <b>15</b>(2): 274–87. <a target=xrefwindow id=d29458e6526 href="http://www.ncbi.nlm.nih.gov/pubmed/27050509">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6529 href="https://doi.org/10.1016/j.celrep.2016.03.037">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726267982">F1000 Recommendation</a></span></li><li><a name=ref-179 class=n-a></a><span class=label>179. </span>&nbsp;<span class=citation><a name=d29458e6542 class=n-a></a>Dougan M, Dougan S, Slisz J, <i> et al.</i>: IAP inhibitors enhance co-stimulation to promote tumor immunity. <i>J Exp Med.</i> 2010; <b>207</b>(10): 2195–206. <a target=xrefwindow id=d29458e6553 href="http://www.ncbi.nlm.nih.gov/pubmed/20837698">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6556 href="https://doi.org/10.1084/jem.20101123">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6560 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2947073">Free Full Text </a></span></li><li><a name=ref-180 class=n-a></a><span class=label>180. </span>&nbsp;<span class=citation><a name=d29458e6570 class=n-a></a>Fischer K, Tognarelli S, Roesler S, <i> et al.</i>: The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells. <i>Front Immunol.</i> 2017; <b>8</b>: 202. <a target=xrefwindow id=d29458e6581 href="http://www.ncbi.nlm.nih.gov/pubmed/28326081">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6584 href="https://doi.org/10.3389/fimmu.2017.00202">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6588 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5339542">Free Full Text </a></span></li><li><a name=ref-181 class=n-a></a><span class=label>181. </span>&nbsp;<span class=citation><a name=d29458e6597 class=n-a></a>Pan W, Luo Q, Yan X, <i> et al.</i>: A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity. <i>Biochem Pharmacol.</i> 2018; <b>154</b>: 127–35. <a target=xrefwindow id=d29458e6608 href="http://www.ncbi.nlm.nih.gov/pubmed/29679556">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6611 href="https://doi.org/10.1016/j.bcp.2018.04.020">Publisher Full Text </a></span></li><li><a name=ref-182 class=n-a></a><span class=label>182. </span>&nbsp;<span class=citation><a name=d29458e6620 class=n-a></a>Clancy-Thompson E, Ali L, Bruck PT, <i> et al.</i>: IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells. <i>Cancer Immunol Res.</i> 2018; <b>6</b>(1): 25–35. <a target=xrefwindow id=d29458e6631 href="http://www.ncbi.nlm.nih.gov/pubmed/29187357">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6634 href="https://doi.org/10.1158/2326-6066.CIR-17-0490">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6638 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5754232">Free Full Text </a></span></li><li><a name=ref-183 class=n-a></a><span class=label>183. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726972000"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29458e6647 class=n-a></a>Chesi M, Mirza NN, Garbitt VM, <i> et al.</i>: IAP antagonists induce anti-tumor immunity in multiple myeloma. <i>Nat Med.</i> 2016; <b>22</b>(12): 1411–20. <a target=xrefwindow id=d29458e6658 href="http://www.ncbi.nlm.nih.gov/pubmed/27841872">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6661 href="https://doi.org/10.1038/nm.4229">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6665 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5515246">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726972000">F1000 Recommendation</a></span></li><li><a name=ref-184 class=n-a></a><span class=label>184. </span>&nbsp;<span class=citation><a name=d29458e6678 class=n-a></a>Kearney CJ, Lalaoui N, Freeman AJ, <i> et al.</i>: PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF. <i>Cell Death Differ.</i> 2017; <b>24</b>(10): 1705–16. <a target=xrefwindow id=d29458e6689 href="http://www.ncbi.nlm.nih.gov/pubmed/28665401">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6692 href="https://doi.org/10.1038/cdd.2017.94">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6696 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5596429">Free Full Text </a></span></li><li><a name=ref-185 class=n-a></a><span class=label>185. </span>&nbsp;<span class=citation><a name=d29458e6705 class=n-a></a>Xiao R, Allen CT, Tran L, <i> et al.</i>: Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer. <i>Oncoimmunology.</i> 2018; <b>7</b>(9): e1471440. <a target=xrefwindow id=d29458e6716 href="http://www.ncbi.nlm.nih.gov/pubmed/30393585">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6719 href="https://doi.org/10.1080/2162402X.2018.1471440">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6723 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6209421">Free Full Text </a></span></li><li><a name=ref-186 class=n-a></a><span class=label>186. </span>&nbsp;<span class=citation><a name=d29458e6733 class=n-a></a>Kim DS, Dastidar H, Zhang C, <i> et al.</i>: Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms. <i>Nat Commun.</i> 2017; <b>8</b>(1): 344. <a target=xrefwindow id=d29458e6744 href="http://www.ncbi.nlm.nih.gov/pubmed/28839138">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6747 href="https://doi.org/10.1038/s41467-017-00324-x">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6751 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5570934">Free Full Text </a></span></li><li><a name=ref-187 class=n-a></a><span class=label>187. </span>&nbsp;<span class=citation><a name=d29458e6760 class=n-a></a>Giardino Torchia ML, Munitic I, Castro E, <i> et al.</i>: c-IAP ubiquitin protein ligase activity is required for 4-1BB signaling and CD8<sup>+</sup> memory T-cell survival. <i>Eur J Immunol.</i> 2015; <b>45</b>(9): 2672–82. <a target=xrefwindow id=d29458e6774 href="http://www.ncbi.nlm.nih.gov/pubmed/26096449">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6778 href="https://doi.org/10.1002/eji.201445342">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6781 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4562866">Free Full Text </a></span></li><li><a name=ref-188 class=n-a></a><span class=label>188. </span>&nbsp;<span class=citation><a name=d29458e6790 class=n-a></a>Nadella V, Mohanty A, Sharma L, <i> et al.</i>: Inhibitors of Apoptosis Protein Antagonists (Smac Mimetic Compounds) Control Polarization of Macrophages during Microbial Challenge and Sterile Inflammatory Responses. <i>Front Immunol.</i> 2018; <b>8</b>: 1792. <a target=xrefwindow id=d29458e6801 href="http://www.ncbi.nlm.nih.gov/pubmed/29375545">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6804 href="https://doi.org/10.3389/fimmu.2017.01792">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6808 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5767188">Free Full Text </a></span></li><li><a name=ref-189 class=n-a></a><span class=label>189. </span>&nbsp;<span class=citation><a name=d29458e6817 class=n-a></a>Ebner P, Poetsch I, Deszcz L, <i> et al.</i>: The IAP family member BRUCE regulates autophagosome-lysosome fusion. <i>Nat Commun.</i> 2018; <b>9</b>(1): 599. <a target=xrefwindow id=d29458e6828 href="http://www.ncbi.nlm.nih.gov/pubmed/29426817">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6831 href="https://doi.org/10.1038/s41467-018-02823-x">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6835 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5807552">Free Full Text </a></span></li><li><a name=ref-190 class=n-a></a><span class=label>190. </span>&nbsp;<span class=citation><a name=d29458e6844 class=n-a></a>Gradzka S, Thomas OS, Kretz O, <i> et al.</i>: Inhibitor of apoptosis proteins are required for effective fusion of autophagosomes with lysosomes. <i>Cell Death Dis.</i> 2018; <b>9</b>(5): 529. <a target=xrefwindow id=d29458e6855 href="http://www.ncbi.nlm.nih.gov/pubmed/29743550">PubMed Abstract </a> | <a target=xrefwindow id=d29458e6858 href="https://doi.org/10.1038/s41419-018-0508-y">Publisher Full Text </a> | <a target=xrefwindow id=d29458e6862 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5943300">Free Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 03 Dec 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1889.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1889.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Cell Signalling and Cell Death, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, 3052, Australia<br/> <sup>2</sup> Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, 3050, Australia<br/> <p> <div class=margin-bottom> Najoua Lalaoui <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> David Lawrence Vaux <br/> <span>Roles: </span> Funding Acquisition, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1889/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 03 Dec 2018, 7:1889 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.16439.1">https://doi.org/10.12688/f1000research.16439.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Lalaoui N and Vaux DL. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=17966 data-id=16439 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16439.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1889/v1/pdf?article_uuid=fbb18850-c659-477f-ac38-0eef0d73193c" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.16439.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Lalaoui N and Vaux DL. Recent advances in understanding inhibitor of apoptosis proteins [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1889 (<a href="https://doi.org/10.12688/f1000research.16439.1" target=_blank>https://doi.org/10.12688/f1000research.16439.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=16439 id=mobile-track-article-signin-16439 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16439?target=/articles/7-1889.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17966 /> <input name=articleId type=hidden value=16439 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Christine J Hawkins</strong>, Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Australia </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Mads Gyrd-Hansen</strong>, Nuffield Department of Clinical Medicine, Ludwig Institute for Cancer Research, University of Oxford, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 03 Dec 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1889.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1889.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=42210-41425></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=42211-41426></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1889/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>03 Dec 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Christine J Hawkins</strong>, Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Australia </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Mads Gyrd-Hansen</strong>, Nuffield Department of Clinical Medicine, Ludwig Institute for Cancer Research, University of Oxford, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1889.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1889/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding inhibitor...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1889/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1889/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1889/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Lalaoui N and Vaux DL');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1889/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1889",
            templates : {
                twitter : "Recent advances in understanding inhibitor of apoptosis proteins. Lalaoui N and Vaux DL, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1889/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding inhibitor of apoptosis proteins", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding inhibitor of apoptosis proteins", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/16439/17966")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "17966");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "41425": 0,
                           "41426": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "896475fa-4008-4a76-9e2a-703ccd102094";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1889.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1889.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1889.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1889.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1889.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>